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Thesis summary 
 
This thesis has been written in the format of three papers: a systematic review, empirical 
study and a critical reflection. Paper 1 presents a systematic review and thematic 
synthesis which explores patients lived experience of consenting to research during a 
life-threatening emergency. Four studies met the inclusion criteria. Themes highlighted 
the importance of communication, the patient-professional relationship and decision-
making paradigms in increasing patient’s confidence in emergency medicine research 
and their role in the consent process. Further implications for clinical and research 
practice are discussed. 
 
Paper 2 presents a qualitative study that aimed to explore women’s experiences and 
views on the acceptability of consenting to a randomised controlled trial for the 
treatment of postpartum haemorrhage. 14 women and their partners were interviewed. 
Framework analysis was used to interpret the data and four central themes emerged 
highlighting the influence of individual and systemic factors on women’s comfort with 
the overall consent process. Women’s views of the acceptability of consenting to 
research during a postpartum haemorrhage are contingent on both individual and 
systemic factors. An understanding of these factors can inform future research protocols 
but also clinical practice. Improvements to future obstetric consent strategies are 
discussed.  
 
Paper 3 presents a critical reflection on the process of conducting the thesis and 
therefore it is not intended for publication. The implications of the research for clinical 
practice and the relevance to and role of clinical psychology in research, emergency 
medicine and obstetric care are discussed. Reflections on personal and professional 
development are also discussed.  
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Abstract   
Objective - To synthesise patients’ experiences and views on consenting to research in 
emergency medicine settings.  
 
Method - A literature review was conducted. EMBASE, CINAHL, MEDLINE and 
PsychINFO databases were systematically searched, in addition to hand searching of reference 
lists, to identify relevant papers. Papers were included if they were published in a peer reviewed 
journal, written in the English language and investigated patients experiences of consenting to 
an emergency research trial using a qualitative or mixed method design. Following the 
identification of relevant studies a thematic synthesis was conducted to explore key themes 
within and across studies to answer the review question.  
 
Results – Four papers matched the eligibility criteria. Patient populations included cardiac, 
stroke and obstetrics. Five analytical themes were generated from the literature; saving lives, 
risks and delays, professional-patient communication, capacity to decide and confusion about 
decision-making paradigms. Clinical and research implications of the themes are explored. 
 
Conclusion – The five themes highlight the importance of communication and the patient-
professional relationship and clarification of decision-making paradigms in increasing patient’s 
confidence in emergency medicine research and understanding their role in research consent 
processes. Consent in research needs to be conceptualised not only as a legal event but also an 
ethical patient-centred process that requires shared information and discussion. The findings 
can be used to guide improvements in patients experience and understanding of consent 
protocols and policies in emergency research and, more broadly, across research and clinical 
practice.  
 
Keywords: informed consent, emergency medicine research, patient views, clinical research, 
research participation 
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Background 
Biomedical research is necessary to develop evidence-based treatments in emergency medical 
settings (1-3), however it poses significant legal and ethical challenges (4,5) and continues to 
be a topic of debate (6). Legal and ethical frameworks (7-9) are in place to ensure that the four 
pillars of medical ethics; autonomy, beneficence, non-maleficence and justice, are upheld to 
protect patient’s rights both within standard clinical practice and research (4). ‘Informed’ 
consent is embedded within the moral pillar of self-determination and is central to research and 
clinical ethics. The process of gaining informed consent for a proposed intervention should be 
an open and ongoing dialogue between the patient and the professional (10) where the patient 
is supported to understand disclosed information on risks, benefits and requirements and is able 
to retain and use this information to make and communicate a reasoned and voluntary decision 
(4). Informed consent is not just signing a form (11,12). The value-base and process of 
informed consent overlaps with the concept of shared-decision making in clinical practice (11).  
 
In both clinical practice and research, professionals are obligated to not only ask for patients’ 
consent but evidence how they conducted this process. Delany’s ‘iceberg’ framework of 
consent highlights systems that influence the process of gaining informed consent and the 
difficulties integrating these in clinical practice (13). The framework describes the tip of the 
iceberg as the actions taken by the professional to obtain consent (e.g. what information is 
given? how is it communicated? completion of documentation). The second and third sections, 
which are still visible, are professional guidelines to support practitioners and legislation which 
governs the overall process. The fourth section of the iceberg, lying below the surface and often 
not explicitly considered during the process, comprises the ethical theories underpinning the 
concept of autonomy. Legally, professionals are obligated to disclose information regarding 
possible risks and benefits, but there is no legal requirement for them to have an in-depth 
understanding of the ethics and values-base underpinning the concept of informed consent (14). 
 
This review explores the process of consent in emergency research trials from the perspective 
of patients with a life-threatening condition. Whilst patients are often treated in emergency 
medical settings for non-life threatening conditions, gaining informed consent for clinical 
procedures and research is inherently different in this situation to those of medical emergency. 
In the later there is a need for rapid assessment of patient symptoms (15) and treatment 
decision-making, rendering these situations time-pressured, fraught, with patients often 
temporarily lacking capacity due to loss of consciousness, physical pain, psychological distress 
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or cognitive confusion (16). In addition, when patient’s lives are under threat the significance 
of clinical decisions is heightened. Acknowledging these substantive differences, this review 
focuses on situations of medical emergency and uses the terms emergency medicine/medical 
emergencies to refer to the treatment of life-threatening conditions.  
 
The processes of gaining consent in emergency medicine hold ethical and practical challenges 
(16). Legislation safeguards patients’ right to autonomy but in doing so can be a barrier to the 
evolution of future medical interventions (17). Without the progression of emergency medical 
interventions professionals risk contravening the principles of beneficence and non-
maleficence through no fault of their own (1,15). In the last decade, quantitative and qualitative 
research exploring patients’ attitudes to consent to research in medical emergencies has 
increased in response to this need for progress. Several studies have reported patient views and 
experiences of aspects of emergency medical research, including views on the necessity of 
emergency research (18-21); perceived understanding of trial and research terminology; 
perceived capacity to give informed consent and internal and external barriers and motivators 
for agreeing to research in this context (22-27). In addition, researchers have investigated the 
acceptability of different consent paradigms such as surrogate consent, deferred consent or 
exception from informed consent for patients (28-30).  
 
Despite the increase in primary research on this topic, only two reviews have been conducted 
(16,31) and only the latter used a systematic search strategy. The most recent systematic review 
highlighted patient’s motivations and reservations about emergency research. However, the 
review included studies which assessed the attitudes of patients who were treated for non-life 
threatening conditions in emergency settings; used emergency department convenience 
samples and used hypothetical trial scenarios. As such the review did not explore in detail the 
experiences and views of patients who had lived experience of being admitted to hospital with 
a life-threatening condition and enrolled in an emergency research trial. 
 
The aim of this review is to synthesise study findings on patients’ lived experiences of 
participating in emergency research trials, to advance current practice in emergency research 
and clinical settings.  
 
 
 
14 
Method 
Search Strategy 
The development of the search strategy and database selection were informed by prior scoping 
searches. Subject headings and text words relating to ‘consent for research in emergency 
medical conditions’ were applied using Boolean operators. Search terms were deliberately 
broad to enable a high sensitivity search to review all potentially relevant papers. Qualitative 
methodology was not used as a search term due to reportedly poor indexing of qualitative 
studies and titles that lack the keywords describing the article (32). EMBASE (1947-), 
CINAHL (1984-), MEDLINE (1946-) and PsychINFO (1806-) databases were searched on 
31st December 2016, in addition to hand searching of reference lists, to identify relevant 
papers. Examples of the search strategies used in each database are provided in Appendix 2.  
 
Study Selection  
Duplicate citations were removed and titles and abstracts of the retrieved papers were screened 
for relevance. Abstracts that did not provide enough information regarding the eligibility 
criteria were kept for full-text review. The full texts of potentially relevant papers were read 
and evaluated by the author and a peer healthcare professional against the criteria checklist. 
Discrepancies between reviewer’s ratings were discussed and resolved.  
 
Inclusion/exclusion criteria 
Papers were included if they were reported in the English Language; a peer-reviewed journal; 
used a qualitative or mixed methodology; used an adult population; and reported patients 
experience/views/attitudes of emergency research consent processes during treatment for a life-
threatening condition. Papers were excluded if they were review articles; used populations 
from non-emergency settings or patients who attended emergency departments for non-life 
threatening conditions; used solely quantitative outcomes; or used paediatric populations. The 
U.S. Department of Health and Human Services Food and Drug Administration Office (FDA) 
criteria of a life-threatening condition “a disease or condition where the likelihood of death is 
high unless the course of the disease or condition is interrupted” (33) was used to distinguish 
between life-threatening and non-life threatening conditions. A paper selection criteria 
checklist was developed using the PICOS (Population, Intervention, Comparators, Outcomes, 
Study designs) template as guidance (refer to Appendix 3). 
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Search results 
Initial searches identified 777 studies. Following de-duplication across databases, 662 studies 
were screened for relevance using the titles and abstracts. 10 additional papers were found 
through hand searching. 27 full texts were read and assessed against the review criteria and 
four studies were judged as eligible for inclusion in the synthesis. Figure 1 shows a PRISMA 
(preferred reporting items for systematic reviews) diagram detailing the results and paper 
selection process for the systematic search (34).  
 
Quality Assessment 
Included studies were quality assessed by the author. Qualitative studies were assessed using 
the CASP (Critical Appraisal Skills Programme checklist; (35)). The CASP was designed by 
a multidisciplinary working group to help develop an evidence-based approach in health and 
social care (36). Mixed method studies were critically assessed using the MMAT (Mixed 
Method Assessment Tool; (37)), specifically developed to provide quality appraisal criteria for 
studies included in systematic mixed studies reviews (38). Although in development, 
evaluations have shown that the MMAT meets the agreed standard for content validity (39) 
and reliability (40, 41). The MMAT is one of a limited selection of tools for assessing the 
methodological quality of mixed method studies. Two reviewers conducted quality assessment 
of the full text papers: the first author and a peer health professional. Relevant data from each 
paper was extracted to support and evidence quality rating decisions. Although the CASP does 
not have a scoring system, the first author translated the CASP answers into numbers (e.g. 
‘Yes’ =1, ‘Can’t tell’ and ‘No’ = 0) to gain a score that could be converted to a percentage to 
aid interpretation across the two tools. Quality ranges were not stipulated by either tool; 
therefore, the first author considered 80-100% = high quality, 50-80% = moderate and <49% 
= as low quality.  
 
Data synthesis and analysis method  
After reviewing several approaches including meta-synthesis (42); narrative synthesis; and 
framework synthesis (43), both researchers agreed that thematic synthesis, as described by 
Thomas and Harden (44) was the best fit for the research objectives. Thomas and Harden 
developed the approach for use in health promotion and public health; to explore stakeholder’s 
views on the appropriateness and acceptability of specific health interventions to inform 
practice and policy. 
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Figure 1: PRISMA detailing systematic review process 
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to identify individuals lived experience and views on consenting to research in a life-
threatening emergency setting and to use this information to consider improvements to the way 
in which research consent pathways are implemented in emergency clinical practice. Thematic 
synthesis has been widely utilised in other systematic reviews synthesising primary qualitative 
studies in medical settings (45-47). Critics state that reviewers should be cautious that they do 
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thematic synthesis was it is considered “epistemologically-neutral” (49) and as such it can be 
applied to aggregative, configurative and mixed approaches to synthesis (50). In addition, the 
stages of thematic synthesis have been reported in published papers as well as process 
examples, thereby providing transparency (44). 
 
Data synthesis was conducted by CP using the method described by Thomas & Harden (44). 
The qualitative findings section of each paper, including quotations and authors’ interpretive 
narratives were extracted and transferred verbatim into a Word document. The views of carers 
or staff were excluded from the analysis. The synthesis consisted of 3 stages; 1) free line-by-
line coding; 2) the development of descriptive themes and 3) the generation of analytical 
themes. Multiple readings of the extracted data were conducted to achieve immersion. The 
author developed initial codes inductively to ensure true representation of the data; as such they 
evolved through the process. The final codes were then grouped according to comparable or 
contrary concepts and descriptive themes were developed to provide context. Finally, 
descriptive themes, which represented the original findings of the primary studies, were 
translated into analytical themes to address the review question. The process was iterative and 
involved the author’s interpretation and inference of the relative meaning of descriptive themes 
in relation to the review question. The evolution of the thematic findings was regularly 
discussed with the second author during supervision. 
 
Results 
Study characteristics 
A summary of the characteristics of the studies is outlined in Table 1. Four studies with a total 
of 85 patients were included (24, 51-53). Publication dates ranged from 2003-2016. Two of the 
four studies were conducted in the last two years. The remaining two studies were dated and 
were included in Limkakeng et al.’s 2014 systematic review (30). However, Limkakeng et al. 
conducted a meta-summary rather than an in-depth qualitative synthesis.
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Critical appraisal  
Critical appraisal scores ranged from 50-90% (see Table 1 above), showing moderate to high 
quality across studies (see Appendix 4 for detailed notes). There were minor discrepancies 
between the two reviewer’s scores but overall quality ratings categories were the same. Dickert et 
al.’s study was given a total score of 50% because the overall quality score of a mixed method 
study cannot exceed the quality of its weakest component, which was the quantitative part of the 
study. It is important to note that the qualitative part of the study scored 75%. 
 
Inclusion of studies 
No papers were excluded from the analysis and synthesis due to quality rating, instead the quality 
assessment process was used to inform the interpretation of the findings and highlight contribution 
of studies to the overall review findings. The aim of the review was to consider a range of patient 
experiences across emergency medical settings and therefore each qualitative study was deemed 
to hold information that could be meaningful for the review question. 
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Ethical considerations 
Ethical approval was reported in three of the studies (24, 52-53). In Gammelgaard’s published 
paper (51), ethical approval was reported for the randomised controlled trial ‘DANAMI-2’ but not 
for the qualitative sub-study. It is interesting, given the focus of the studies that only one study 
reported gaining informed consent for the qualitative study. The issue of confidentiality was not 
discussed in any paper (52).  
 
Research aims, methodology and design 
All four studies provided a clear statement of aims with justification of the relevance to research 
and clinical practice. Three studies used a single method qualitative design (51-53) and the 
remaining study (25) used a mixed method design (closed-ended questions and open-ended 
questions). Only three studies gave a rationale for their chosen design (51-53). The aim of the 
review was to synthesise qualitative data, therefore only the qualitative section of Dickert et al.’s 
study was analysed (25). 
 
Populations and trial details 
Populations within the four studies were as follows: myocardial infarction (24, 51); stroke (53) 
and peripartum (52). Lawton et al.’s participants were involved in the Got-it trial, a UK-wide 
randomised controlled trial (RCT) for women with a retained placenta. The trial investigated 
whether use of glyceryl trinitrate (GTN) spray as compared to placebo, facilitated delivery of the 
placenta without having to attend theatre for manual or surgical intervention. Mangset et al. (53) 
interviewed patients who were eligible for the Third International Stroke Trial (IST-3), a 
randomised controlled trial (RCT) of thrombolytic drug treatment within the first 6 hrs after a 
stroke. Both the remaining studies focused on medical treatment for myocardial infarction (24, 
51). Dickert et al. participants were part of a trial of coronary ischemic post-conditioning in 
patients with ST-elevation myocardial Infarction (STEMI). The population in Gammelgaard et 
al.’s (51) study were candidates for the second DANish Acute Myocardial Infarction study 
(DANAMI-2) which compared primary angioplasty with fibrinolysis (usual practice) in the 
management of acute myocardial infarction. 
 
Sampling and data collection 
All but one study gave detailed information about the recruitment of participants (51-53). Two 
studies only recruited individuals who had consented to take part in the trials (24, 52). Sampling 
methods were reported in all studies. Two studies reported using purposive sampling (24, 52), 
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although Gammelgaard et al. referred to this as ‘strategic’ sampling. The remaining two studies 
used convenience sampling (24, 53). Dickert et al. (24) reported that all individuals who had 
participated in the parent AMI trial were eligible for the qualitative study; excluding those who 
were non-English speaking, were not the individual who had been asked for consent initially and 
were unable to answer interview questions. Similarly, Mangset et al. (53) recruited individuals 
who had been asked to participate in the IST-3 and the only other exclusion parameters were 
patients with severe aphasia, severely reduced consciousness and dementia. 
 
Only one study referred to a form of saturation (52). Lawton et al. (52) stated that data collection 
ceased following data saturation which they reported as ‘no new findings or themes identified in 
new data collection’. Having used a phenomenological method, Mangset et al. (53) would not be 
expected to report data saturation as the philosophy of the method is to capture rich personal 
accounts from the sample and explore commonalities, rather than saturation of themes. It would 
be expected that Gammelgaard et al. (51) report on theoretical saturation given grounded theory 
as the choice of method and as such this reduces the credibility of the findings. Dickert et al. (24) 
did not highlight how data collection was ceased. Due to this and use of convenience sampling 
there a risk of sampling bias. Sample size ranged from 11 to 32, all of which are adequate numbers 
for the methodologies. As such, most studies had small patient samples, although this is expected 
in qualitative studies. Both Dickert et al. (24) and Gammelgaard et al.’s (51) studies were biased 
towards male participants likely due to the naturally higher prevalence of this medical condition 
in men. Each of the four studies used interviews as the method of collecting data. Lawton et al. 
(52) was the only study that also interviewed staff involved in the clinical trial.  
 
Data analysis  
Reports of the data analysis process were varied. Both Mangset et al. (53) and Lawton et al. (52) 
described this in detail; referencing the use of in-depth coding and multiple analysts to aid 
triangulation and provide credibility checks. Gammelgaard (51) reported adhering to grounded 
theory protocol but no examples were given and it was unclear who conducted the data analysis. 
The use of participants quotes to illustrate findings were diverse across the studies. Given Dickert 
et al. (24) conducted a mixed method study, it was expected that there would be fewer quotes 
reported in comparison to the three single qualitative studies. 
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Data findings 
All papers were considered to contribute relevant information to the literature base on patients 
lived experienced and views on providing informed consent during a medical emergency, and to 
each specialist emergency medical domain (24, 51-53). However, some studies presented more 
in-depth findings than others (52-53). Dickert et al. (24) provided a highly descriptive rather than 
interpretative account of patients’ views in line with the mixed method study design utilised. 
Gammelgaard et al. (51) despite stating adherence to grounded theory principles, they did not 
report findings in relation to a developing theory which brings in to question the credibility of the 
data analysis and subsequent findings. 
 
Capacity to consent 
All studies discussed issues around patients’ capacity to consent to emergency research. Some 
studies emphasised patients perceived level of capacity by using direct verbatim quotes. In others, 
authors inferred patients’ level of capacity. In Mangset et al.’s study (53), authors deduced that 
patients did not appear to have capacity to make an informed decision to enrol in research given 
that they had no understanding of the trial nor did they understand the conditions of research (e.g. 
randomisation). Gammelgaard et al. (51) highlighted because of post-consent interviews it was 
impossible to test whether patients fulfilled competence criteria during the emergency. However, 
authors explored patients perceived level of competency given their physical, emotional and 
cognitive state at the time of the emergency. Authors inferred that patients perceived level of 
competence was attributed to their physical and emotional wellbeing at the time of the emergency 
(51). However, even patients who were alert and pain-free misinterpreted research terminology 
and pathways. Patients in `Dickert et al.’s study (24) reported limited understanding of the trial 
and research processes, believing that they could choose between treatment arms. Patients 
described being in pain, under stress and feeling time-pressured. Authors concluded that patients 
did not appear to have had capacity to make an ‘informed’ decision at the time of the emergency 
(24). Women in Lawton et al.’s study (52) described making ‘snap decisions’ without knowing or 
understanding the full facts of the research. Lawton et al. (52) suggested that women appeared 
unable to make an ‘informed’ decision due to lacking capacity because of pain and exhaustion.  
 
Researcher bias 
Two studies reported limited details about potential researcher bias (51-52) and accounted for the 
role of authors in the research process. The remaining two studies (24, 53) did not report any 
statement on the influence of the researcher – participant relationship. In addition, authors did not 
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discuss reflexivity; the influence of researcher preconceptions and values. This again brings in to 
question the reliability of the findings in these studies. 
 
Thematic synthesis 
The thematic synthesis of the studies generated 40 initial codes; 14 descriptive themes; and five 
analytical themes, see Table 2 for the link between the data analysis and the development of the 
themes. The analytical themes are summarised below using primary and secondary evidence. The 
contribution of each study to the themes and sub-themes is detailed in Table 3. 
 
Saving Lives  
The first analytical theme centred on the motivators for patients’ enrolment in emergency 
research: underpinned by the descriptive sub-themes of trust in medical profession and system, 
advance medical treatments and increase own chances of survival. Individuals believed that 
the trial provided a chance to save their life and potentially future lives. They reported a strong 
belief in the competency of medical professionals and trusted the hospital system to manage 
critical situations safely: “I assume that there are well-trained, professional people who are in 
charge, so I feel safe” (53). Some individuals reasoned that if doctors thought it was a risk worth 
taking to test new interventions then they were happy to take part: “…then I might as well 
participate because after all they needed somebody to take part in this trial to find out about it” 
(51). These individuals recognised the need for participation in research to advance treatment and 
were encouraging of this societal role, believing it was their “duty” (53). Others reported the more 
serious their condition was the more likely they were to enrol in research as a chance to save their 
life: “…for me the most important thing was that I was given treatment and nothing else, what 
else they did, makes no difference” (53) and “I’d have done anything to sort of avoid having to go 
to theatre” (52). 
 
Risks and delays 
In contrast to the more societal-focused motivators of participation, the reasons for declining 
emergency trial enrolment were self-focused. The three sub-themes were: urgency - wanting 
immediate treatment, “I don’t want to risk my life for an experiment” and treatment 
“lottery”. Individuals reported that receiving immediate treatment was the most important thing 
to them: “I was in a panic and for me the most important thing was that I was given some 
treatment” (53). 
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Research trial involvement often involved, or was perceived to involve, waiting which was 
deemed unacceptable and provoked emotions such as anger, disbelief and fear. Randomising to 
treatment arms and transferring to another ward or even hospital were reported as obstacles to 
rapid treatment (51). Following on from this theme, many individuals did not want to take what 
                                                
1 One initial code was considered relevant to two descriptive themes it was categorised under both themes. Number 1 or 2 
representing duplication. 
Analytical themes Descriptive Themes Initial free codes 
 Saving Lives Trust in medical profession 
 
If doctors think it is ok 
Explanation for trial 
Time taken to explain information (1)1 
To advance medical treatments People need to take part to find out new things 
Benefitted from past research 
To save future lives 
Increase own chances of survival Adequacy of existing treatment 
Severity of condition: last option 
Grateful to have options 
Risk & Delays 
 
 
 
 
 
 
 
 
 
Urgency - wanting immediate 
treatment 
Trial would require waiting 
Priority = immediate treatment 
“I don’t want to risk my life for an  
experiment” 
 
Fear of research being prioritised over patient well-being 
Fear of dying 
Risks considered to outweigh benefits 
Severity of condition: reluctance to take risks 
Media coverage of trials 
 
Treatment “lottery” Blinding = the right to know!  
Treatment ‘lottery’ is unfair  
Science needs randomisation but discomfort of being part 
of it 
Life is precious 
Professional-
patient 
communication 
 
Interaction during consent-gaining  Not the right time to ask 
Influence of past negative experiences of healthcare 
Time taken to explain information (2) 
 
Capacity to decide What risks? Not able to process risks 
Told there were ‘no’ risks 
Information processing reduced 
 
Emotionally overwhelmed 
Lack of time to decide 
Unable to read or retain the information  
Lack of understanding of research terms 
I’ll try anything! Anything to get rid of the physical pain 
Prevent more invasive procedures 
Can I say no? The right to say no! 
Not a good time to object 
Making a snap decision 
 
Life and death situation 
Unsure of own capacity - on reflection 
Anxiety after making the decision 
Decision-making   
paradigms 
RCT - So I choose between the 
emergency treatments? 
Belief the patient decides between treatments  
Belief that experimental treatment must be better 
The Doctor should decide – they 
know best! 
Experts should make decisions 
Belief that professionals ‘chose’ treatment based on 
clinical need 
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they perceived to be a risk to their life for the sake of research due to anxieties about dying, 
research goals being prioritised over patient wellbeing and deliberation of risk-benefit ratios: 
“Anything that can benefit myself or anybody else, I don't have a problem with it as long as there 
is no detriment to me” (24). Most individuals recognised the need for research in medical 
emergencies to develop new treatments but reported ambivalence about their own role in this 
process due to treatment “lottery” (51). Several individuals believed they had the right to know 
what treatment they would be receiving and felt a placebo option was unnecessary (53).  
 
Professional-patient communication 
Some individuals did not feel that professionals recognised the difficulty in deciding to partake in 
research during a medical emergency: “She [the physician] said ‘I know”, and I said ‘you can’t 
be serious; I said I can’t possible decide…And she said ‘But I have to ask you, I know it’s not fair 
but I have to ask…” (51). Others felt supported by professionals, believing they recognised the 
difficult decision they were asking patients to consider and had done their best: “I think they 
genuinely probably told me everything about the trial, but my head was elsewhere” (52). A 
minority of individuals commented on how a doctor’s request to read trial information, may in 
itself feel like pressure to enrol: “I think it should be both (physician and patient), but I don't think 
it should be a pressured decision. The patient shouldn't feel pressured. Nine times out of ten when 
a person of authority speaks, that's pressure within itself” (24).  
 
Capacity to decide 
The fourth analytical theme identified that patients appeared to have reduced capacity to make an 
‘informed’ decision regarding partaking in emergency research. Five descriptive sub-themes 
supported this analytic theme: what risks; reduced ability to process any information; I’ll try 
anything; can I say no; making a snap decision. Many individuals reported not reading or 
processing information on possible risks: “I don’t think I read anything about any risks” (51). 
Some individuals reported being told by professionals that in fact there were “no” risks involved 
and this impacted on their decision (51). Some individual’s felt confused and unable to make an 
informed decision due to lack of time to read and process the information fully as a result of their 
medical condition: “at that point I was cross-eyed and it was just about all I could take in” (52). 
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A medical emergency can be an extremely stressful and distressing time and some individuals 
appeared to find being asked to decide exacerbated their sense of distress: “It was introduced at a 
stage in a condition that was for me critical…I was in a panic…” (53). Further to this, a minority 
felt that a life and death situation was not the time to ask someone to consent to a research trial: “I 
couldn’t make any decisions whatsoever because my head was spinning; I was having a heart 
attack!” (51). Several individuals found that they were physically and emotionally unable to attend 
and comprehend information: “I don't remember because everything was going so fast and I was, 
like, freaking out myself” (24). Many individuals re-counted that at the point of being asked to take 
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part in emergency research they were willing to try anything to gain immediate treatment, relieve 
the pain, prevent longer treatment or reduce emotions such as fear and panic: “the only thing I can 
tell you is, when that pain hit, you don't want to talk about nothing; you don't want to hear about 
scientific this or that. All you want to do is get this resolved right away” (24). A few individuals 
reported believing that research trials were normal and that to object would be considered irrational 
and they would be looked upon unfavourably: “I don’t think it’s normal to react negatively, in 
other words not a good time to object, either” (53). Many individuals reported making an impulsive 
decision without considering the risks and benefits of the trial: I just said yes straightaway, I didn’t 
want to mess around, I just wanted to hold my baby…” (52).  
 
Confusion about treatment decision-making paradigms 
A further analytical theme was confusion about treatment decision-making paradigms (e.g. 
emergency research randomised controlled trial (RCT) vs. usual emergency care), underpinned 
by two descriptive sub-themes: RCT - so I choose between the emergency treatments? and 
Doctors should decide – they know best. Several patients were confused about the trial design 
and what was required of them, believing that they had to choose between treatments arms (51). 
Other individuals believed that they should not be asked to make the decision, but rather medical 
professionals as they were the experts could establish clinical need (24, 53). Furthermore, some 
individuals felt that it was ridiculous to be asked to decide about research when they had no 
foundation medical knowledge to base their decision on: “They are supposed to know aren’t they? 
I don’t know anything about what treatment I needed” (51). Individuals appeared confused 
between the relationship between the doctor and patient in emergency research trials, as opposed 
to standard emergency care believing that treatment was individualised: “...they would see which 
is the right treatment...I think it is a decision of the doctor who is doing the treatment.” (24). 
 
Discussion 
Summary of findings 
Five analytical themes were generated from the synthesis, underpinned by 14 descriptive themes 
and 40 initial codes. The findings are tentative given the small number of papers in the synthesis. 
Patients recognised the necessity of emergency research but several were ambivalent about their 
own role in this process. This appeared to be related to a lack of understanding of trial 
requirements, consent paradigms and ethical concerns centred on risk of harm. Patients who 
demonstrated understanding of the above concepts gave balance to risk and possible benefits. 
However, several patients considered it impossible to make ‘informed’ decisions regarding 
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research during an emergency due to the impact of physical pain, psychological distress and the 
time-pressured nature of the environment. Most patients considered professionals to be doing their 
best in broaching the topic during an emergency, but some felt that the process itself put them in 
an impossible dilemma. A diagram was created to highlight the connection between the five 
analytical themes (see Figure 2). It highlights the influence of contextual factors on patients’ 
decision-making regarding research during a medical emergency. 
 
Figure 2: A schematic representation of the findings of the themes 
 
 
 
Patients’ decisions regarding reasons and reservations (intrapersonal) for enrolment in emergency 
research are influenced by interactions with professionals (interpersonal), the emergency 
environment (context) and comprehension of research designs, language and consent pathways 
(societal). Gaining informed consent in a medical setting is a relational process between patient 
and professional as it requires sharing information, an active discussion and a judgment of a 
patient’s capacity to make a balanced decision. Of importance is the influence of professional’s 
approach to the consent process and the patient’s actual or felt sense of ability to make an informed 
decision during a medical emergency. Further to this, the emergency environment generates 
recruitment challenges regarding time, management style, sense of safety, condition severity and 
resources which may influence patient’s decisions to enrol in research. The final theme and factor 
influencing enrolment in research is patient, family, medical professional and public 
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comprehension of research designs, language and consent pathways. Poor comprehension is likely 
to act as a barrier to successful recruitment in emergency research trials.  
The synthesis highlights areas for improving patient understanding and decision-making in 
emergency medical research. Despite ongoing research over the last 20 years and multiple legal 
and clinical procedural changes, many patients continue to feel ambivalent about enrolling in 
research trials in emergency settings (19-20, 51, 53). The concerns identified in this synthesis 
continue to underpin patients’ decisions to engage or decline entry into emergency research trials.  
 
The importance of the ‘relational’ component of gaining consent 
A factor in the acceptability of the informed consent process in emergency research for patients 
appears to be the relationship between the patient and the asking professional. Gaining informed 
consent in a medical setting is a relational process between patient and professional as it requires 
active discussion and a judgment of a patient’s capacity to make a balanced decision. This is 
important as medical professionals appear to be focused on the procedural duties associated with 
gaining patient consent e.g. the visible tip of the iceberg model ‘what professionals say and do’ 
(13) as highlighted in the analytical theme of professional-patient communication. The label of 
‘informed’ consent does not appear to support the application of consent-gaining as professionals 
appear to see it as a matter of delivering information rather than sharing and discussing 
information with the patient. As such consent-gaining appears to be viewed as an event rather than 
both a legal event and ethical patient-centred process. The ‘delivery’ of the information is likely 
to be the priority during medical emergencies when time is critical in preventing morbidity and 
mortality. Patients are likely to be in acute physical and psychological distress and therefore it is 
imperative that medical professionals are skilled in validating the patients emotional state in 
addition to sensitively ‘sharing’ and discussing trial information in the limited time frame. 
Although patients are required to make an independent decision in research, the values and process 
of discussing consent could be seen to be parallel to shared decision-making frameworks in 
clinical practice (10).   
 
Clinical vs. research – the role of the medical professional 
It is also necessary for professionals consider the influence and power they may inadvertently 
have on patients’ decisions to partake in research (54) due to confusion between standard clinical 
practice and research (therapeutic misconception; (55)) and the differing role of medical 
professionals in these contexts. In clinical settings in western societies, medical professionals are 
considered ‘experts’ whom patients trust to make healthcare decisions. As highlighted by the 
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theme of ‘confusion between decision-making paradigms’ in this synthesis, patients often believe 
the role of the medical professional to be the same within a research context, particularly 
emergency research where there is high chance of morbidity and mortality. Yet the roles of 
professionals are different in accordance with the aims that govern each context. Standard clinical 
practice aims to promote the health of individual patients and patient-centred care (56). Clinical 
research on the other hand aims to generate useful knowledge for future patients and therefore the 
role of the professional is to prioritise the needs of the community over individuals. For 
recruitment purposes, it is important that patients are given clear and succinct verbal and written 
documentation that denotes the difference between clinical practice and research decision-making. 
Not only could this provide clarity on terminology but also promote patient decision-making, 
which in healthcare is often passive in nature (57). In addition, it is crucial that medical 
professionals can critically reflect on the influence of their position and beliefs and subsequent 
interaction with the patient during the informed consent process.  
 
Complexity of research terminology & consent documentation 
Informed consent documentation is often extensive and burdened with complex terminology to 
cover a vast array of eventualities, making it difficult for patients to understand (58). This is the 
case in non-emergency clinical settings but is heightened in emergency medical situations due to 
the additional factors of acute pain, psychological distress, cognitive confusion and levels of 
consciousness (59-60). Patients often do not fully read or understand the consent forms (46-48). 
For patients who have limited literacy skills, being asked to consider reading trial information 
during a stress-inducing emergency medical situation is likely to exacerbate comprehension 
difficulties. Although difficult to facilitate during medical emergencies, it is important for 
professionals to clarify patient understanding of trial processes for consent to be as informed as 
possible in this context.  
 
Strengths and limitations of the review 
Strengths of the review include the application of a systematic and iterative search strategy to 
access a comprehensive data set; a second reviewer at the full-text screening stage; and application 
of thematic synthesis, a well-documented approach developed for analysing qualitative data (44). 
Published critical appraisal tools, reported in health systematic reviews were used to assess the 
quality of the included studies.  
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The main limitation of the review is the substantial shortage of primary qualitative literature on 
this topic and methodological limitations within studies. Only four studies were found to be 
relevant to the review question, highlighting a shortage of studies in this area. All studies had 
small samples although this is to be expected in qualitative research. Studies were conducted in 
western countries and predominantly with individuals’ over the age of 45; this could be considered 
a natural bias of conditions such as stroke and cardiac arrest. Further to this, study populations 
were limited to a small number of specialities (e.g. stroke, cardiology, general emergency and 
obstetrics) and one study utilised a mixed method design and therefore provided limited data on 
contextual factors underpinning individual beliefs and behaviours in emergency research. The 
Confidence in the Evidence from Reviews of Qualitative Research (CERQual) tool (61) could 
have been used in an additional analysis to assess the levels of confidence to place in the findings.   
 
Implications for future research 
There is limited up-to-date literature on patients’ in-depth views and experiences of being part of 
an emergency trial for a broad range of life-threatening conditions. There is also a lack of literature 
on the in-depth views of patients who decline to partake in these emergency trials. As a result, 
continued research is needed in this area, not only to contextualise patient decisions regarding 
research enrolment but to provide a platform to discuss the evolving nature of emergency medicine 
research and influence legal, ethical and clinical protocols. This would improve the legitimacy 
and credibility of emergency research for patients and promote shared decision-making and 
inclusivity. 
 
Conclusion 
Five analytical themes were highlighted in the thematic synthesis of qualitative studies exploring 
patients’ views and experiences of consent processes in emergency research. These included 
motivators and inhibitors underpinning patient’s decisions to accept or decline trial involvement; 
a lack of understanding of the distinctions between clinical practice and clinical research; 
differences in professional-patient communication and interaction and the ability of the patient to 
make an ‘informed’ decision. The themes identify areas of opportunity to promote patient 
understanding and comfort during consent processes in emergency research, several of which are 
also relevant for supporting the broader process of informed patient consent across clinical 
settings.  
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Abstract 
 
Objective: To explore the experiences of patients and their partners who participated in a trial of 
treatment for postpartum haemorrhage and the acceptability of the research consent process to 
inform the implementation of acceptable consent pathways in emergency obstetric research. 
 
Method: Semi-structured face-to-face interviews were conducted with fourteen women and two 
partners. Framework analysis was used to interpret the data. 
 
Results: Four central themes emerged from women’s birth, PPH, and subsequent OBS2 
enrolment narratives; the birth before the bleed; losing blood; women’s perceived ability to make 
an informed decision and preferences for future research consent pathways.  
 
Conclusion: Women’s views of the acceptability of consenting to research during a postpartum 
haemorrhage are contingent on both individual and systemic factors. An understanding of these 
factors can inform future research protocols but also clinical practice. Improvements to future 
obstetric consent strategies are discussed.  
 
Trial registration: ISRCTN ref: ISRCTN46295339 (01.07.2013); EudraCT: 2012-005511-11 
(28.11.2012), UKCRN ref: 13940.  
 
Keywords: consent, emergency medicine research, postpartum haemorrhage, clinical research, 
research participation, childbirth, intrapartum trials 
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Background 
Postpartum Haemorrhage (PPH) 
Postpartum haemorrhage (PPH) is the most common form of major obstetric haemorrhage (1) and 
a leading cause of maternal mortality in developing countries (2). In the UK, PPH accounts for 
10% of all direct maternal deaths (3) and between 2004-2013 prevalence rates of PPH in England 
have increased from 7% to 13.8% (3, 4). PPH is defined as blood loss of ≥500ml after vaginal 
delivery or ≥1000ml after caesarean section (5). Blood loss over 1000ml is considered major and 
subdivided into two categories: moderate ≥ 1000-2000ml and severe ≥ 2000+ (3). PPH is 
categorised as primary and secondary depending on onset of bleeding: primary = ≥24hrs post birth 
and secondary = ≥12 weeks post birth (6). Origins of postpartum haemorrhage are uterine 
atony, trauma, retained placenta, and coagulopathy often referred to as the four T’s: tone, trauma, 
tissue and thrombin (7,8). The management of PPH includes four mechanisms: communication, 
resuscitation, monitoring and investigation and measurements to control the bleeding (9). In the 
last decade, there has been an increase in the conduct of clinical trials investigating the 
effectiveness of different medical interventions for the treatment of PPH across the world (the 
WOMAN trial (10); FIB-PPH (11).  
 
The experience and impact of having a PPH 
Although a normal and natural process, childbirth can lead to not only physical but psychological 
trauma (12,13). Birth trauma defined as belief of ‘actual or threatened injury or death to the mother 
or her baby’ (14) can result in psychological difficulties such as posttraumatic stress disorder 
(PTSD) and depression (15,16). Prevalence rates of PTSD following childbirth are between 1-3% 
in Western countries (16). Studies have found that birth-related risk factors associated with the 
development of PTSD are negative experiences pre-and during delivery, obstetric emergencies, 
operative birth, fear of losing the baby and a lack of perceived staff support during the birth 
(15,17). Individual factors identified as increasing the risk of women experiencing PTSD 
following birth include previous experiences of trauma (e.g. sexual abuse), mental health 
difficulties and lack of social support. For some women, experiencing a blood loss during birth 
may lead to psychological distress and the association between PPH and PTSD is currently being 
explored (18). Previous research conducted with women who experienced a PPH of 1500ml+ 
found no increased risk of experiencing postpartum depression or PTSD (19). Most qualitative 
PPH studies have focused on women who have experienced severe blood loss (2,000ml+) and 
required invasive treatment (20,21). These studies have highlighted that factors such as blood loss 
management, reduced communication from professionals, separation from family and fearing 
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death, increases psychological distress during and following a PPH. These themes have recurred 
in recent studies of women’s experience of PPH with a mild-moderate (500-2000ml) blood loss 
suggesting these factors are associated with psychological impact rather than blood loss severity 
per se (22). Therefore, it is important to acknowledge that regardless of the presence or absence 
of risk factors, trauma is in the ‘eye of the beholder’ (23) and research exploring women’s 
experience of birth complications can provide useful information to inform future clinical 
management of birth complications. 
 
Research in obstetric settings 
The nature of obstetric practice means that emergency situations are relatively frequent (24) and 
conducting intrapartum research in obstetric settings is invariably complex. Childbirth involves 
considerable physical and psychological exertion and pain (25) and can inhibit a woman’s 
capacity to make informed decisions about standard clinical procedures and research (26). Further 
factors such as fear of labour, antenatal health complications and prior traumatic birth experiences 
can influence labour management and ability to give informed consent. In addition, analgesics 
used in labour have been shown to reduce cognitive functioning, specifically short term memory 
retrieval (27). Historically, pregnant women have been excluded from clinical trials due to being 
viewed as a ‘vulnerable’ population in research governance (28) but research during antenatal, 
intrapartum and postpartum care is essential for the development and implementation of evidence-
based medical treatment. Distinguishing the difference between clinical treatment and research is 
an inherent problem in medical research, resulting in misplaced patient beliefs that doctors in 
research trials prioritise individual best interests and that treatment will always benefit the 
individual (29, 30). During intrapartum emergency trials, women may be more susceptible to this 
“therapeutic misconception” (29) due to the limited time to comprehend the nature of the research, 
preoccupation with fear of harm to baby or own death, confusion on details of emergency 
treatment and cultural belief about the doctor’s role. Therapeutic misconception can therefore 
compromise the legitimacy and acceptability of intrapartum research.   
 
Research consent pathways 
Although ethically ideal, true informed consent can be difficult to obtain in many medical settings. 
Broad obstacles to informed consent include patient literacy, research and health literacy, cultural 
differences, communication and recruitment strategies and professional understanding and 
comfort with research trials (31). Informed consent is further compromised in medical 
emergencies due to factors such as time pressure, treatment window, reduced cognitive 
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functioning, pain levels and fear of death. The requirement to obtain consent prior to study 
procedures in trials of emergency care reduces recruitment and introduces delays in treatment that 
would not occur outside the confines of the trial (32). The need to provide evidence based care to 
patients in emergency situations is therefore compromised by an inability to deliver trials that test 
timely interventions. To mitigate this, alternative consent processes have been proposed for 
clinical trial research: proxy consent and exception from informed consent (33,34). 
 
Obstetric specific consent pathways 
Midwifery associations have highlighted the importance of research being conducted “with 
women, not on women” (35) and therefore, finding optimum obstetric research consent pathways 
remains a priority. Obstetric research has the additional consent pathway of antenatal information. 
Obstetric guidelines have advised that information given is in line with the suspected risk of 
occurrence e.g. it would be unethical to give all pregnant women detailed information on 
complications that occur in less than 1/100 women e.g. uterine inversion (36). Antenatal 
information given as part of a staged consent pathway and in line with level of suspected risk is 
supported by consumer groups and professional bodies (35,36). 
 
Intrapartum studies have mainly opted for brief antenatal information so as not to cause undue 
distress and fear pre-labour, followed by full study information at time of trial eligibility 
(WOMAN Trial, (10); Release Trial, (37)). However, during an obstetric emergency it may not 
be ethical or practical to provide full research information due to capacity issues or limited 
treatment window. A recent development to obstetric research has been the oral consent pathway 
(36): provided women have been given antenatal information, brief oral consent can take place at 
the time of the complication and full written consent obtained at a later stage (34).  
 
To date, no qualitative research has been conducted on exploring women’s experience and views 
of consenting to research during a postpartum haemorrhage. The closest relevant research 
conducted by Lawton et al. investigated womens’ experiences of being invited to partake in a 
peripartum trial for the treatment of a retained placenta (38). Health professionals were also 
interviewed to explore their experiences and views of the consent-gaining process. Findings 
highlighted that women and professionals had different views on whether ‘informed’ consent was 
gained, with women reporting the influence of antenatal and intrapartum events on their decision-
making ability and staff focusing on disclosure of information about risks. The women in the study 
suggested the implementation of antenatal trial information to increase awareness, however 
41 
professionals were reluctant to include this pathway due to the belief that it would cause undue 
distress to women in pregnancy. 
 
Rationale and aims 
Qualitative research can provide valuable insight into stakeholder’s experience of health 
complications and medical research, which can help improve future clinical care and advance 
research procedures. PPH provides an apposite context for exploring consent as it is an anticipated 
obstetric emergency condition that requires treatment within a limited timeframe. Obstetric 
emergencies are distinctive in that professionals are responsible for the welfare of two individuals: 
the mother and baby. Further to this obstetric care is reliant on connected services e.g. antenatal 
clinics, delivery wards, post-natal community follow-up. Evidence based treatment and 
understanding of stakeholder’s experiences is essential to enable the delivery of patient-centred 
care. Regarding specific PPH trials, most have sampled homogeneous groups due to the variation 
of causation and treatment, using categories such as method of delivery and level of blood loss as 
exclusion criteria. In addition, the OBS2 trial utilised an antenatal information pathway. The 
OBS2 trial aimed to contextualise women’s experience of the consent process within an 
emergency obstetric setting e.g. PPH and evaluate the acceptability of this process to inform 
consent protocol in future PPH trials. Therefore, the aims of the OBS2 qualitative study were two-
fold: 
(i) To explore the experiences, views and preferences of women who gave consent to 
participate in a trial of treatment for postpartum haemorrhage. 
(ii) To explore the acceptability of the consent process (e.g. antenatal information pathway and 
intrapartum consent) and how future clinical trials of PPH can be optimised. 
 
Method 
Ethical approval  
Full ethical approval for the OBS2 trial was obtained from the Research Ethics Committee for 
Scotland (Ref: 13/SS/0008) in March 2013. Local Trust Research and Development approvals 
were obtained prior to the start of the study. The qualitative sub-study was granted approval via a 
substantial ethics amendment in December 2015 (see Appendix 6). 
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Study Design  
The qualitative study was a sub-study of the Obstetrics Bleeding Study Two (OBS2), a 
prospective, randomised, double-blind, placebo controlled trial that took place between June 
2013-16 and investigated whether early infusion of fibrinogen concentrate during a major PPH 
reduced the total number of allogeneic blood products transfused compared to placebo (39). 
Women were included or excluded according to the criteria detailed in Tables 3 and 4 below. 
 
Tables 3 and 4: OBS2 study inclusion and exclusion criteria 
 
OBS2 consent pathway 
At the time of a PPH women may not have full capacity to give informed consent to participate 
in research trials because of factors such as pain, medication and physiological factors associated 
with blood loss such as nausea, dizziness and disorientation. As such a graded approach to consent 
was adopted by the OBS2 trial. The staged consent protocol is highlighted in more detail in the 
published trial protocol (39). In brief, all eligible women in the recruiting centres received an 
introductory leaflet (see Appendix 7) in the antenatal period describing the study and consent 
process and were asked to sign a form indicating either that they did not wish to take part in the 
study or to acknowledge that they had received and understood the information. The form was 
part of the woman’s hand held maternity records. If the woman had received the antenatal leaflet 
but had not indicated either of the above options, professionals were still able to invite them to 
take part in the trial. Consent was then either taken antenatally, for women who were deemed ‘at-
risk’ or had planned caesareans, during labour or when the PPH occurred. If deemed to have 
43 
capacity to provide consent the woman was given an intrapartum patient information sheet and 
provided written or verbal consent. If deemed not to have capacity the protocol of assigning a 
legal representative was followed.  
 
Recruitment and sampling 
Of the 60 women recruited in Cardiff and Vale NHS health board 42 (70%) completed an 
expression of interest form for future PPH studies including talking about their experience of 
being part of OBS2. All 42 women were contacted in accordance with convenience sampling. 
This non-probability sampling method has no additional parameters other than participants are 
willing and able to participate. This sampling method was used in favour of purposive sampling 
because the population pool of 42 women was deemed sufficiently varied, apart from 
demographics which was inherently biased towards White British ethnicity. Limitations of the 
sampling method are detailed in the discussion. The 42 women were contacted via email by the 
research midwife explaining that a researcher (CP) would be contacting them by telephone in the 
near future to invite them to participate in the study unless they requested otherwise, this was 
considered an opt-out strategy. 
 
Data collection 
Semi-structured face-to-face interviews were conducted by CP a trainee Clinical Psychologist 
with 6 year’s postgraduate clinical experience, at a location convenient to the women. To 
understand and interpret the women’s experience of being invited to take part in research during 
a PPH it was important to recognise the importance of the experience from the woman’s 
perspective and understand the context in which the consent was given. Therefore, the interview 
schedule was divided into two parts: labour, birth and PPH experience and experiences of the 
OBS2 trial and consent process. The interview schedule, information sheet and consent form (see 
Appendices 8-10) were designed with input from the trial management group, and based on the 
guidance in the protocol which was developed in collaboration with a maternity lay advisor. The 
interview schedule was piloted with a participant and a prompt to refer to the antenatal information 
sheet was added. No other changes were made to the interview schedule and the pilot interview 
was therefore included in the data. Interviews were audio-recorded using an encrypted digital 
recorder and transferred, stored and analysed on a secure network drive.  
 
Two guiding principles of sampling methods in qualitative research are appropriateness and 
adequacy (40). Bowen (41) argues for the importance of sample adequacy over sample size. 
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Sample adequacy relates to the demonstration that data saturation has been reached, defining this 
as obtaining depth and breadth of information which ‘sufficiently’ answers the research question 
(42). The concept of ‘sample adequacy’ was used by the author to guide the data collection process 
rather than the concept of thematic/data saturation which is limited as data can never be truly 
saturated, as there is always new data to be discovered (43). Data collection ended after 14 
interviews were conducted at which point the first author considered the data to have achieved 
sample adequacy; specifically, no new concepts emerged during the interview and the research 
question could be sufficiently answered.  
 
Data Analysis 
Rationale for using framework analysis 
Qualitative methods are often aligned with specific epistemological and philosophical approaches 
which shape the data collection and analysis process. However, framework analysis is not and as 
such can be applied to inductive or deductive thematic analysis (44, 45). Critics have suggested 
that focusing entirely on affiliating qualitative methods with epistemological and ontological 
theories can overshadow the need to ensure methodological robustness (46). Some researchers 
have suggested that pragmatism should be applied to choosing the appropriate method for 
addressing specific research questions, rather than focusing on the underlying philosophy (47). 
Framework analysis was deemed suitable for several reasons. Firstly, framework analysis is 
centred on the method of thematic analysis which has no alliance to a specific epistemological 
theory and as such it was deemed a good fit for the aims of research which were underpinned by 
balancing deductive and inductive principles of analysis. Secondly, the study utilised semi-
structured interviews that produced substantial verbatim text with “fractured discourse” (48). The 
framework tool is helpful in managing large quantities of textual data in a systematic and 
transparent manner. 
 
Applying principles of framework analysis and conducting a thematic analysis 
Interview transcripts were anonymised then coded using the qualitative coding software NVivo 
Pro version 11 for Microsoft. Framework analysis (49) was used to identify, analyse and report 
patterns within and across the interviews. The approach enables a systematic and transparent 
analysis of the material while facilitating the use of pre-existing empirical evidence to inform the 
study method. Framework analysis consists of a series of five stages: familiarisation, development 
of a thematic framework, indexing, charting, and mapping data to enable interpretation. During 
the familiarisation stage CP listened to recordings, read memos from a reflective diary and 
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discussed with supervisors. The interview schedule and emergent themes identified during the 
familiarisation stage informed the initial working thematic framework to filter and index the data. 
CP indexed all the data, identifying sections of the data that corresponded to a theme on the 
framework. The framework was tentative throughout indexing to allow for new and unpredicted 
themes generated by participants. Double-coding took place on (15%) transcripts to ensure 
indexing consensus and applicability of the framework to the data and research questions. After 
the final transcript was indexed the thematic framework was finalised and the data were 
systematically charted and summarised into framework matrices. This aided the first author to 
enter in to the mapping and interpretation stage and conduct a thematic analysis; identification of 
recurrent themes within and across participants, typologies and linkages and possible explanations 
(48,49). The participants were assigned pseudonyms rather than participant number, so that the 
quotes had a ‘voice’. Appendices 11-14 show examples of the analysis process.  
 
Use of Supervision 
OBS2 was based in a general health setting, as part of a trials unit. Supervision with the second 
and third authors, the academic supervisor and clinical supervisor, was invaluable whilst 
negotiating these new systems. The fact that the academic supervisor was a Clinical Psychologist 
and an experienced trials unit researcher enabled open discussions about the complexities of 
transitioning to and from the different roles, specifically psychologist to researcher. Discussions 
took place regarding the first author’s role and position in the project; reflecting on the 
transferability of psychologist’s meta-competencies to medical and trial settings and how being a 
psychologist rather than a medical professional/researcher enabled taking a ‘naïve/not-knowing’ 
position.  
 
Reflexivity Statement 
I, the first author, conducted the qualitative sub-study as part of my Doctorate of Clinical 
Psychology (DClinPsych) thesis. I am a 30-year-old White British middle class female, in a long-
term relationship with no children. As part of the DClinPsych, I split my time between two 
locations: South Wales and a town in the South West of England. I have 7 years’ experience of 
working clinically in the NHS with individuals across the lifespan. I have limited experience 
working psychologically in a medical setting, apart from a child health placement during the 
DClinPsych. However, my mother was a senior paediatric nurse and as such I grew up with a 
strong awareness and interest in the health profession and the health care system. I have never 
been treated for a medical emergency, nor have I taken part in a clinical trial. I would describe my 
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therapeutic approach as integrative, informed mainly by attachment and systemic ideas. I consider 
myself a passionate clinician and as such feel comfortable in engaging individuals in reflective 
conversations about their experiences. It is important to note that my position of Trainee Clinical 
Psychologist may have elicited preconceptions and beliefs from participants and as a result 
influenced the answers they gave.  I have experience of conducting qualitative and quantitative 
research. Specifically, I have conducted research using thematic analysis, however I am a novice 
in using the Framework analysis approach. As such, I took time to connect with experienced 
qualitative researchers in the trials unit who were proficient in applying the framework approach 
in a health setting. During the research, I kept a reflexive journal. I took time to note down my 
experiences during the process of data collection and analysis and monitored and considered how 
beliefs and assumptions that emerged may have influenced the way I engaged with the research 
and how participants responded to me. 
 
Results 
Response rate 
Of the 42 women invited to take part, 22 women did not respond to the interview invitation during 
the period of recruitment: July-November 2016. Possible reasons for women not wishing to take 
part in the study are: the timescale between the birth and the invite to interview; competing 
demands; physical or psychological difficulties because of the PPH and not wishing to talk about 
these; believing they had nothing of value to say and lack of recollection, understanding or interest 
in the study. Of the 20 women who were contacted, none declined participation in the research 
study however practical difficulties prevented interviews taking place with six women. 14 (33%) 
women were interviewed, two of whom were interviewed with their birth partners. One woman 
had entered the trial via the legal representative consent pathway due to the severity of her PPH 
and subsequent medical symptoms. However, the legal representative was not interviewed. 
Interviews lasted between 25 and 70 minutes.  
 
Characteristics of participants 
Table 5 below shows some of the individual characteristics of the women. Numerical details such 
as age and blood loss have been grouped in to ranges to aid anonymity. Some demographic 
information is reported as overall participant characteristics rather than individual characteristics 
due to the risk of breaching anonymity. Of the 14 women, 12 were of White British ethnicity, one 
was White Other and one was White Non-British. 11 women were interviewed between 6-9 
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months after the birth, two were interviewed 10-13 months and one was interviewed 14-18 
months.  
Table 5: Individual Characteristics 
Pseudonym Age Range Delivery Method Blood Loss 
ml 
Primipara vs. 
Multiparous 
Lauren 40-45 Vaginal 2000-2999 Multiparous 
Sarah 25-29 Emergency caesarean 1000-1499 Primipara 
Libby 30-34 Emergency caesarean 1500-1999 Multiparous 
Amanda 30-34 Vaginal 1500-1999 Primipara 
Emma 35-39 Vaginal 3000-3999 Multiparous 
Jessica 30-34 Forceps 1500-1999 Primipara 
Anna 25-29 Vaginal 1000-1499 Multiparous 
Caroline 25-29 Forceps 1000-1499 Multiparous 
Mary 40-45 Planned caesarean 1500-1999 Primipara 
Chloe 25-29 Forceps 4000-4500 Primipara 
Abigail 30-34 Forceps 1500-1999 Primipara 
Rebecca 30-34 Forceps 2000-2999 Primipara 
Alexandra 35-39 Planned caesarean 1500-1999 Multiparous 
Jane 40-45 Planned caesarean 4000-4500 Multiparous 
 
Seven women were first time mothers and the remaining multiparous. All women gave birth to 
live babies that survived. One woman gave birth to twins, the remaining gave birth to singletons. 
The range of delivery methods were: planned caesarean (n=3); spontaneous vaginal birth (n=4); 
emergency caesarean (n=2); and assisted delivery using forceps (n=5). All the women interviewed 
were medically reported to have had a ‘moderate’ primary PPH and blood loss ranged between 
1500-4500ml. In accordance with the PPH classification of a moderate PPH: nine women had a 
‘major’ PPH and five had a ‘severe’ PPH. Two women required blood transfusions. One women 
had a retained placenta. Three women were allocated to the interventional arm of the study, the 
remaining the placebo arm. 
 
SES and education levels were not collected as part of the original OBS2 data set, however it was 
possible to estimate SES based on participant postcodes. Postcodes were input into an online tool 
which calculates The Welsh Index of Multiple Deprivation (WIMD, 50): a measure of multiple 
deprivation that is both an area-based measure and a measure of relative deprivation. WIMD is 
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currently made up of eight separate domains of deprivation. Each domain is compiled from a 
range of different indicators including income; employment; health; education; access to services; 
community safety; physical environment and housing. It is interesting to note that out of 14 
participants, 10 were living in an area that was ranked as among the ‘50% least deprived place in 
Wales’. Out of the remaining four women, two were living in areas ranked as ‘10% most deprived’ 
and two were living in areas ranked as ’30-50% most deprived’. This highlights that a 
disproportionate number of women (approximately 71%) who took part in the interviews were 
from the ‘least deprived’ areas in Wales. 
 
Themes 
Following analysis and interpretation, four themes emerged each with sub-themes (see Table 6).  
 
Table 6: Themes and sub-themes 
Themes Sub-themes 
Theme 1: “…induced when not needed to, 
an epidural that wore off and forceps and 
episiotomy and lots of stitches" - The birth 
before the bleed  
Ø Subtheme 1.1: The impact of previous complications 
 
Subtheme 1.2: “I couldn’t see an end…” 
 
Subtheme 1.3: Straightforward vs. complications 
Theme 2: “I’ve got like a blur of you know, 
um well not blood everywhere but um, 
towels and all sorts you know” - Losing 
blood 
Subtheme 2.1: "…all of a sudden loads of people 
started rushing into the room” - Awareness of the bleed 
 
Subtheme 2.2: “I tried to be focused as I could be…” - 
Response to the bleed 
 
Subtheme 2.3: “Left holding the baby” 
Theme 3: “Are you of sound mind?” 
Women’s perceived ability to make an 
informed decision 
 
Subtheme 3.1: Recollection of antenatal information 
 
Subtheme 3.2: Registering information 
 
Subtheme 3.3: Timing of the consent dialogue  
 
Subtheme 3.4: Motivation to take part 
 
Theme 4: “…everybody has a different way 
of dealing with things kind of on an 
emotional level, so it’s probably very 
personal.” Preferences for future research 
consent pathways 
Subtheme 4.1: Understanding research language 
 
Subtheme 4.2: Antenatal information - signposting vs. 
discussion  
 
Subtheme 4.3: Sensitivity of intrapartum consent 
 
 
49 
Theme 1: “…induced when not needed to, an epidural that wore off and forceps and 
episiotomy and lots of stitches." - The birth before the bleed  
 
Subtheme 1.1: The impact of previous complications 
All multiparous women experienced complications before, during or post one of their previous 
births. None of the women had previously experienced a post-partum haemorrhage. Prior 
complications significantly impacted on women’s current birth experience, including a need to 
know that their baby was healthy:  
 
" “Is he okay? just tell me (baby’s) okay”, because…the first emergency caesarean I had, that was 
all a scary story…”  
          Emma  
Subtheme 1.2: “I couldn’t see an end to it…” 
 
Women who experienced labour and delivery complications described waves of physical and 
emotional discomfort, as though on a rollercoaster: 
 
“…so I'd go into labour, I'd get as far as the hospital, and you know I'd get all that way and they'd 
be like yes you're in labour but you're in the early stages. So, I'd go home and then everything 
would stop and it would be three days later.” 
 
         Chloe 
Women reported management plans being in a constant state of flux: 
 
"I think initially it was oh I think we need to go do something.  Then it was oh we'll wait and see 
if he does...And then they said no we're going to rush you straight in…”   
                                   Sarah 
 
Some women felt completely helpless and panicked due to labour not progressing: 
 
“baby felt utterly stuck and...I did feel like I got to that point where actually panic set in and I 
thought this is just never going to happen, this is never going to be, I couldn’t see an end to it 
really..." 
                       Jessica 
 
When medical professionals decided to intervene, women described feeling emotionally relieved 
and a new sense of hope:  
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“…I did feel an absolute massive wave of relief that it [protracted labour] was over…almost like 
euphoric really…” 
               Jessica 
 
 
“…I went from the worse pain I’ve ever known in my life to absolutely no pain"  
               Abigail 
 
Subtheme 1.3: Straightforward vs. complications 
 
Three women had no labour or delivery complications prior to the blood loss, all of whom had 
planned caesareans. The remaining women experienced complications that required one or more 
interventions: induced labour, the use of forceps, an episiotomy or an emergency caesarean. Some 
women experienced complications due to professional error: 
 
“…induced when not needed to, an epidural that wore off and forceps and episiotomy and lots of 
stitches." 
    Caroline 
 
Others, because of the baby becoming stuck: 
 
“…in the wrong position so she was going back up and not coming so they was trying to turn her, 
nothing was happening…" 
    Rebecca 
 
Women who were unable to give birth as planned, felt extremely “upset” when they were unable 
to give birth “properly” as described by Emma. Some felt as though “everything was going wrong” 
[Abigail].  
 
Theme 2: “I’ve got like a blur of you know, um well not blood everywhere but um, towels 
and all sorts you know” - Losing blood 
 
Subtheme 2.1: "…all of a sudden loads of people started rushing into the room” - Awareness 
of the bleed 
Most women reported becoming aware of difficulties following the onset of sudden physical 
symptoms or a change in pace by professionals, while others described being completely oblivious 
to any complications. Some women spoke about sensing something was wrong immediately after 
the birth: 
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“I got very breathless I couldn’t breathe and I kept saying I can't breathe, then I knew something 
was wrong."  
Chloe 
 
These symptoms impacted on women’s ability to greet and hold their babies for the first time 
and carry out their motherly role: 
 
"you’re a new mum again and you’re freaking out you can’t feed your baby…you’re not getting 
that initial holding in”.   
Alexandra 
 
and their awareness of knowing where their baby was: 
 
"I wasn’t aware of where he was or what happened to him and actually that was quite hard”  
  
Chloe 
 
  
Several women reported awareness that circumstances had changed because of the sudden arrival 
of more medical staff and panicked conversation: 
 
“I heard somebody say um “Oh have you got that emergency blood just in case?”  
Abigail 
 
Although many women recognised that something was wrong they were unaware it was a result 
of blood loss. The remaining women reported being “oblivious” to the blood loss or the extent of 
the complications due predominantly to high pain levels and exhaustion which had impacted on 
their ability to understand the situation: 
 
“I mean I was a bit kind of, I…delirious is a bit of an exaggeration but you do feel quite fuddled 
when you’re in that much pain…”  
Jessica 
 
 
“…like I said I was so exhausted and because it had gone on, like been in labour for the four days 
before”  
Anna 
 
As a result, many women only registered the complications after it happened whilst in recovery. 
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Subtheme 2.2: “I tried to be focused as I could be…” - Reaction to the bleed 
Women’s response to having a bleed linked closely with their level of awareness. Experiencing a 
feeling of being disconnected from the situation, some women did not respond as perhaps they 
would usually: 
 
“I knew it wasn’t all quite going to plan but I was too out of it to worry too much”  
Sarah 
 
Some women were focused on their family than on their own health. For example, several women 
did not feel panicked by the situation since the birth had taken place before the bleed and therefore 
knew their baby was safe: 
 
“Yeah, I could tell there was something, but I wasn’t overly, well I say overly bothered, because 
I knew ((baby’s name)) was out fine…”  
  Amanda 
 
However, a small number of women were concerned for their babies due to health complications, 
reducing consideration of their own medical situation: 
 
“I think if ((baby’s name)) was alright, I think we would have probably realised more what had 
happened to me…”  
Anna 
 
Several women demonstrated pragmatic responses to the bleeding; trusting in the competencies 
of professionals to stop the blood loss or conversely trying to remain calm as the professionals 
became more panicked:  
 
“I didn’t feel terrible, I just thought “Well, it’ll get sorted one way or the other, even if I have to 
go back in [to theatre].”  
Mary 
 
Subtheme 2.3: “Left holding the baby” 
Most women reported that their birth partners had witnessed the bleeding as it happened. They 
reported noticing that their partner was distracted at the time but attributing it to being a first-time 
father or feeling “queasy” when in fact it was because they could see “...a big jar filling with 
blood” [Rebecca] and witnessed attempts “…to try and stop the bleeding on the floor" [Abigail]. 
Several women believed the experience had been very distressing for their partners, perhaps more 
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traumatic than for themselves. They attributed this to several factors including their partner’s 
exposed view of the situation as stated above; their partner not being told what was happening: 
 
"but he did say to me that he was just kind of left with the baby not knowing what was 
happening” 
              Lauren 
 
and fearing they were not “going to make it” [Emma]. Jane reported her partner was worried his 
wife would die and he would be left to bring up their children alone. Mary’s partner emphasised 
that Mary didn’t “realise how bad it was!”. 
 
Theme 3: “Are you of sound mind?” Women’s perceived ability to make an informed 
decision  
 
Subtheme 3.1: Recollection of antenatal OBS2 information 
For six of the women, their first memory of the OBS2 trial was the antenatal information sheet 
(AIS) in the maternity packs. This gave them a better understanding of the study protocol and 
participation requirements. Several of the women reported their first memories of the OBS2 trial 
was when they were asked to provide consent: 
 
“…he said, “oh just thinking ahead over the next hour or so” “um if this were to happen, how do 
you feel about um being part of a research project?’…and I said “yes” straightaway…”  
 
Mary 
 
Many women’s first OBS2 memory was at the point of consent. All but two women remembered 
consenting, only a few remembered clear coherent details of the conversation: 
 
“…but I do remember they did explain it to me thoroughly…and I said yeah that’s absolutely fine 
and they say, they said “are you of sound mind?” and I was like as sound as I could ever be.”  
 
Caroline 
 
Three women signed consent forms prior to having planned caesareans due to pregnancy 
complications and one of these women remembered professionals confirming her consent at the 
time she became eligible to enter the trial. The collective narrative of women’s awareness and 
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understanding of the trial during the bleed highlights the impact of blood loss on women’s ability 
to register and process consent documents administered during treatment. Some women appeared 
able to make an informed decision at the time of the emergency because of having read and 
understood the antenatal information sheet: 
 
“…they sort of, they handed the form back to me and I had the opportunity to look at it and I went 
“I’ve already read this…so I just went yeah give me the form I’ll sign now.”  
     Sarah 
 
One woman required a personal legal representative due to the severity of the blood loss and 
subsequent medical symptoms. This woman had read and signed the AIS and had made an 
informed decision to take part prior to the birth, a decision she had also shared with her partner: 
 
“((male partner’s name)) did it for me because I was under general anaesthetic when you actually 
need to do the consent. But I’d filled out all the forms to say I was happy with it all before….”  
 
Chloe 
 
Subtheme 3.2: Registering information 
Women reflected on professional’s communication about the blood loss. Many reported despite 
staff making conscious efforts to keep them informed of the situation, they were unable to register 
the information: 
 
“…I think they were probably explaining, they were talking to me, weren’t they? but I think I 
wasn’t really registering because I was thinking about ((baby)).”  
Anna 
 
“…but I kept feeling like I wasn’t told anything…but ((partner)) tells me that they did keep telling 
me what was going on, obviously, I just didn’t take it in.” 
                  Chloe 
 
A minority of women remembered clear details of the conversations with medical professionals 
about the blood loss and treatment plan:  
 
“so they said they needed to check how much, and then if there was any issue then we’d talk about 
[what] needs to happen”  
Caroline 
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Subtheme 3.3: Timing of the consent dialogue 
Most women who gave intrapartum consent felt the timing of consent to the OBS2 trial was 
appropriate given the complexities of the medical situation. Women who had been aware of the 
AIS and reported feeling informed when they gave intrapartum consent found the process more 
acceptable. Some women who did not remember seeing the AIS reported that they “didn’t mind” 
being asked to consent to the trial despite being in a hectic environment and not having much time 
to decide:  
 
“…I don’t mind doing it but I think it is just not…it’s quite hard to decide whether you want to 
or not isn’t it?”  
      Jessica 
 
Other women felt at the time they were approached they were in no state to register the 
information due to being mid contractions, in pain or in theatre after an arduous labour: 
 
“…down theatre and being jumped on type of thing...I weren’t quite you know in the state of mind 
I suppose to know what they were on about…to be honest.”  
 
     Libby 
 
“…I just shouted at her to quickly get to the end so I can sign it, I didn’t even have to sign it I just 
put a line on a piece of paper, I couldn’t even hold a pen, I was such a mess at the point that she 
could have said anything to me and I would have just said yes.”  
    Jessica 
 
The researcher interpreted that these women felt frustrated at being asked to consider enrolment 
at this specific time in their birth. It is particularly interesting given women’s feelings about the 
timing of consent, that no woman explicitly stated they felt the intrapartum consent process was 
‘unacceptable’. The closest to this was Abigail who reported she “could have done without it”. It 
is interesting that professionals appeared to focus on the procedural elements of informed consent 
e.g. asking patients to read information and then sign a form, and highlights how this is prioritised 
over process, such as a shared discussion: 
 
 
“…they asked me to sign the form then I think…you know the signature was all over the place…”  
 
   Libby 
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Subtheme 3.4: Motivation to take part  
A minority of women reported being motivated by the potential for the trial medication to help 
stop the blood loss and “save my life” [Jane]. These beliefs highlight the influence of therapeutic 
misconceptions on decisions to partake in research; as although women may have been given the 
drug, this is not the fundamental aim of a trial. Recognition that women may be assigned to the 
placebo was not reported. Several women perceived the trial as low risk in terms of the possible 
impact on themselves and were prepared to take part for the benefit of others: 
 
“…that’s no problem, won’t affect me negatively and it will help obviously… you know, research 
for the future, isn’t it?”  
Sarah 
 
“…I trust my doctor you know and I trust the hospital because you know they don’t give me 
anything…could hurt my body”  
Jane 
 
Women spoke about recognising the ‘value’ and ‘importance’ of research to develop better 
obstetric treatment for women in emergency situations:  
 
“…I want to be a part of it and anything I can do to help then great...let me help somebody else…”  
 
Caroline 
 
“…you realise how much you rely on medical assistance that you get, so if you think well actually 
you can be part of something that makes things better I don’t think that’s a bad thing.”  
 
Jessica 
 
Lauren reported “you just say yes don’t you”, suggesting a lack of autonomy to decide and the 
influence of medical paternalism. 
 
Theme 4: “…everybody has a different way of dealing with things kind of on an emotional 
level, so it’s probably very personal.” Preferences for future emergency obstetric consent 
pathways  
 
Subtheme 4.1: Understanding research language 
Several women emphasised the need to use lay terms and research or medical terminology side 
by side in information sheets as often the latter is the language used during the emergency. One 
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partner suggested that information about the randomisation process should be emphasised such as 
the fact you may not be allocated to the experimental arm of the trial: 
 
“…because you’ve signed up for something and…it’s clear that you could get nothing…” 
 
          Mary’s partner 
 
One woman highlighted the need to reassure women that their clinical care would not be 
undermined by being part of the trial: 
 
“…what I understood from reading you would have that whilst waiting for the other drugs to be 
administered, so you wouldn’t not get the treatment by the impact of the study.”  
 
Sarah 
 
Subtheme 4.2: Antenatal information - signpost vs. discussion 
Several women would have valued more emphasis on the study during the antenatal period, but 
recognised that this could be time consuming. Following a visual prompt of the AIS during the 
interview, most women remembered that they had seen or read the OBS2 study information “oh 
that’s right I did get one initially” [Mary]. However, on reflection some women highlighted 
despite having read the AIS they did not register its relevance or connection during the bleed: 
 
“…I certainly did not take it for what it was but then did I read it in great detail? I can’t remember”  
 
Caroline 
 
A minority of women continued to have no recollection of having read the OBS2 information 
sheet pre-birth “I don’t know many people who did actually have that in their packs…” [Libby]. 
Although the women had differing views about the usefulness and trial antenatal information, no 
woman felt it was an unacceptable process. However, many women highlighted it should be 
broached sensitively through discussion with professionals rather than just placed in packs: 
 
“…if it’s something the midwife goes through with you as part of your preparation…you’re 
having a one on one with somebody, it’s not a time where taking on information like that is going 
to be upsetting or that you’re reading it on your own and you might be confused by it.”  
 
Jessica 
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Many women recognised that there is “no one fits all’ process and the information may provoke 
anxiety in some women but not others. Therefore, it is down to personal choice. 
 
 
Subtheme 4.3: Sensitivity of timing of the intrapartum consent 
 
Several women spoke about how a consent process for a trial such as OBS2 could never be 
acceptable to all, and that some may be receptive and others may be disapproving but there was 
no other way than to ask them. Many suggested that consent-gaining should be considered during 
early labour when they are likely to be “a bit clearer with things”. However, one woman who 
consented in theatre, highlighted that an earlier invitation into the trial would have caused her to 
panic: 
 
“I guess that it’s a good time to do it, because personally if it had been mentioned before that, I 
would have panicked, whereas you know, you’ve already gone to theatre, it’s already clear that 
this isn’t an ideal and normal, natural birth.”  
Abigail 
 
She also described had she been asked to consent any later (e.g. at the time of blood loss) it would 
have felt “reactionary” by professionals whereas she felt the timing for her was “proactive”. Other 
women suggested consenting pre-labour however they recognised ultimately it is personal 
preference and for some women this may frighten them more: 
 
 
“…probably in other cases if somebody is doing that just before your birth, you’d be thinking why 
are they telling me? Does this happen all the time? and it’s going to panic you even more.”  
  
Amanda 
 
Some felt that it was important for women to have obstetric trial information prior to birth to aid 
decision-making ability during the emergency: 
 
“It does help. If I hadn’t read that leaflet, if I hadn’t known anything about it and just on that day 
they’d have said ‘oh right we’re doing this study…’ I might have, just because I wasn’t able to 
deal with it at the time, just gone ‘No I’m not interested!’ You know?”  
 
Sarah 
 
Sarah highlighted women may respond with an outright no if they were asked to take part in 
research during a medical emergency that they had no prior knowledge or understanding of. 
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Discussion 
The findings of the study are discussed in relation to the research aims, existing literature and 
theory and implications for clinical practice, clinical research and further research.  
 
To date there has been no research published on women’s experience of consenting to a research 
trial during a PPH; as such these findings provide a basis for future literature. Women’s 
experiences of and views about enrolment into the OBS2 trial and preferences for future obstetric 
research pathways are highlighted, as such research aims were achieved. 
 
Thematic findings and link to existing literature 
Within this study, the researcher interpreted four themes from women’s birth, PPH, and 
subsequent OBS2 enrolment narratives; the birth before the bleed; losing blood; women’s 
perceived ability to make an informed decision and preferences for future research consent 
pathways.  
 
Theme 1: The birth before the bleed 
Most women experienced complications prior to the blood loss and this impacted on their delivery 
experience. Some women became upset at being unable to deliver in accordance with their birth 
plan and described feelings of failure, linking to previous literature on the impact of changes to 
birth plans (51). In addition, some women felt their concerns about physical symptoms during the 
birth were minimised or overlooked. In recent research, women reported feeling as though their 
‘embodied knowledge’ about the progress of their birth, including feeling as though something 
was wrong, was disregarded in favour of the clinician’s clinical evaluation (52). Research has 
shown that dismissal of women’s concerns during birth has been linked to the development of 
trauma symptomology (53). The narratives of women who reported previous birth complications 
highlighted language suggesting experiences of both physical and psychological trauma. Existing 
literature highlights that women often remember birth experiences with strong emotional 
attachments (20, 54), particularly if they experience life-threatening complications. As discussed 
earlier birth trauma is considered “in the eye of the beholder’ (23) and as such is a result of the 
complex interplay of medical, individual, interpersonal and systemic factors. 
  
Theme 2: Losing blood 
Women are often unaware of obstetric conditions such as PPH due to the comparative rareness of 
the condition to other obstetric complications (20) and as such women who do experience it are 
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unprepared. Levels of awareness about the PPH were varied, with some reporting awareness due 
to physical symptoms and the change in pace by professionals whilst others were “oblivious” due 
to high levels of pain, medication and physical/emotional exhaustion from labour. Women 
described several responses to the onset of the PPH, including being pragmatic, feeling 
disconnected and focused on their family which links to findings from previous PPH research (20-
22). Women described their birth partner’s role in the birth and subsequent bleed, and 
unanimously felt that it was more traumatic for their partner due to their view of the situation, 
being left with the baby, lack of communication from professionals and fear of their partner dying. 
These experiences echo previous research (21,22), highlighting the forgotten role of birth partners 
in PPH experiences and the risk of developing trauma symptoms.  
 
Themes 3 & 4: Women’s ability to give informed consent and preferences for future consent 
pathways 
Even without complications it is known that childbirth is a unique context with considerable 
ethical issues (26). This is due to factors such as the reduced opportunity for dialogue between 
professional and expectant-mother because of an inherently stop-start event; responsibility for the 
safety of two lives and physical and emotional vulnerability due to pain and medication. As such 
there are conflicting beliefs about a woman’s ability to give informed consent during labour, for 
clinical treatment pathways. A survey of obstetric anaesthetists found that 70% believed that 
women in active labour would be unlikely to make an informed decision (55). However, others 
suggest that if a woman had capacity to make an informed decision before labour she would retain 
this ability in labour (56). 
 
Many women in OBS2 reported making quick, and not necessarily informed decisions about 
enrolment in the trial, which links closely to Lawton’s findings which highlighted a lack of 
consideration of risks (38). Women also described how pain, tiredness and overwhelming 
emotions impacted on their ability to take on information and focus on and interact with 
professionals, partner and their baby. This reiterates previous literature in the area (20-22), 
particularly findings from previous perinatal trials (56). Researchers in this study found that many 
women felt ‘unable to listen’ and that rapid consent decisions were prompted by irritation. 
Although no woman explicitly stated that they found the intrapartum consent process 
unacceptable, it is implied by the language used in some of the women’s narrative. Many women 
who had no recollection of the AIS felt extremely frustrated when the consent dialogue took place. 
Others who had no recollection of the AIS, appeared to find the consent pathway acceptable given 
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the nature of the obstetric emergency. These findings highlight the influence of antenatal trial 
knowledge on women’s ability and comfort in making research enrolment decisions. Reflections 
on their experiences of the OBS2 consent process informed women’s preferences for future 
obstetric consent processes. All women felt giving antenatal trial information was an acceptable 
stage in the consent process but emphasised the need for sensitive management regarding the 
timing, method and content of information. This reflects recommendations from obstetric 
professional bodies (34, 35).  
 
The findings from the study highlight women’s experiences of enrolling in the OBS2 trial are 
influenced by a complex interplay of sub-systems, each holding individual, interpersonal and 
systemic factors, shown in Figure 3. Women’s experiences of consenting to OBS2, views on the 
acceptability of such consent and preferences for future research pathways are embedded in their 
experiences of birth, blood loss and the consent interaction. 
 
Figure 3: Connection between the themes 
 
 
These experiences/sub-systems influenced women’s overall views of the acceptability of obstetric 
emergency research. This proposal is based on systems thinking: the belief that it is impossible to 
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truly understand a phenomenon by reducing it to basic components and that systemic perspective 
is necessary for comprehending the phenomenon in question (58,59). 
 
Implications for obstetric emergency practice and research 
Interactions and dialogue during a PPH 
During obstetric emergencies, there is an urgent need for treatment (1,7) which often negates the 
provision of information and positive staff-patient interactions. It is vital that obstetric clinicians 
work collaboratively to provide effective treatment for the woman, her infant and the family, this 
includes negotiating the difficult task of effective communication during a medical emergency. 
Effective communication can provide feelings of care and containment for the woman and partner 
and reduce the risk of developing symptoms of psychological trauma. As highlighted by the 
findings in this study, clinicians need to be mindful of women’s experience of previous birth 
traumas and the impact of these on response to current obstetric complications. Clinicians should 
be attuned to women’s early reports of concerns and conduct clinical assessments accordingly.  
 
Understanding medical and research terminology  
Women in the study had mixed levels of health and research literacy. Some had strong knowledge 
and understanding of medical and research terminology, others had limited awareness which may 
have influenced their comprehension of the OBS2 trial. As such some women misinterpreted 
clinical research to be underpinned by therapeutic intent (26), replicating findings from research 
conducted in obstetric (38,57) and non-obstetric emergencies (60-61). Simple strategies such as a 
research noticeboard and leaflets explaining research paradigms and terminology in the antenatal 
clinics may support the development of a culture of research in obstetrics and in turn improve 
women’s awareness of research terminology and active clinical obstetric research trials. 
 
Capacity to consent to obstetric emergency research 
It is well documented that physical and emotional factors associated with childbirth such as pain, 
medication, stress, fear and a focus on the baby (26) can impact significantly on decision-making 
ability. This can be exacerbated when women then go on to experience a significant blood loss 
(21-22). It is therefore debatable whether women can give truly ‘informed’ or ‘true’ consent 
during this experience. As such, the addition of antenatal trial information and a staged consent 
model is preferable and inviting women to consent to intrapartum research needs careful 
navigation. Professionals need to be mindful of individualised experiences of labour and delivery, 
severity and response to blood loss; previous birth or other traumatic complications and the likely 
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influence that these factors will have on a woman’s decision to consent to research trials during 
an obstetric emergency. As stated by one of the women in the study “there is no one fits all” 
approach: some women will find being invited to take part in intrapartum research acceptable and 
others will not, it is a case of professional judgment and assessment of capacity and consideration 
of the medical circumstances.  
 
Antenatal information-sharing process 
Women involved in OBS2 had preferences about antenatal and intrapartum consent pathways. 
Women, who had experienced antenatal discussions with professionals about trial recruitment, 
valued this information-sharing opportunity. Snowdon et al. (21) found that women and their 
partners preferred the concept of an antenatal as opposed to intrapartum consent pathway, stating 
they had a right to know about such trials during their pregnancy. The OBS2 study highlighted 
two types of women: those who were information ‘seekers’ e.g. reading through the whole 
antenatal pack and those who were information ‘avoiders’ e.g. ignoring the information in the 
antenatal pack. The discrepancy between women’s preferences highlights the need for a two-tiered 
approach that adheres to the needs of all stakeholders and the ethics of trials: general information 
sharing through brief antenatal information sheets in packs and publicity in the antenatal clinics 
followed by the opportunity to discuss relevant research trials with an obstetric professional during 
individual clinical consultations. Using this information-sharing approach, women can choose to 
engage or decline discussions with professionals about research trials.  
 
Clinically, midwives are likely to find it difficult to offer to discuss each obstetric research trial 
with every pregnant woman due to large caseloads. In addition, some obstetric clinicians and 
researchers have reported that antenatal pathways would be time-consuming and may cause undue 
anxiety in women who are in fact unlikely to go on to have a PPH (38). Clinicians might lack 
confidence in discussing research paradigms and trials that they are not regularly part of and 
therefore may require additional training and support. Alternatively, roles could be divided so that 
professionals are employed as either a clinical researcher or clinician. This could reduce the 
burden and responsibility on clinicians and the risk of therapeutic misconception. A variance of 
this approach is currently in use in the Organ Donation and Transplantation (ODT) service which 
employs specialist nurses to approach families and discuss consent processes for organ donation 
and liaise with the clinical team of the deceased patient (62). Although this is not a research 
environment, ODT does present ethical, legal and practical dilemmas for authorisation of consent.  
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Future research 
There is a lack of studies exploring the preference and views of women who choose not to partake 
in emergency obstetric research, including targeted PPH studies, due to the difficulties in 
identifying and accessing this population. Yet it is vital that exploring stakeholders’ reasons for 
declining entry in to emergency obstetric research is a focus of future research to inform the design 
and conduct of future obstetric trials with the hope of increasing acceptability and therefore 
participation. Qualitative research is particularly valuable in procuring this information as it 
enables researchers to explore complex attitudes and preferences on a given topic and the values 
that underpin these. Future research may also benefit from assessing preferences and acceptability 
of consenting to emergency obstetric trials over different time points such as within days of giving 
birth and then a follow-up interview three months later. This could enable researchers to see 
whether views are static or dynamic over time, specifically during the PPH recovery period and 
adaption to motherhood. 
 
Methodological Strengths and Limitations 
The researcher used guidance on attaining validity in qualitative psychology (63-64) to 
demonstrate attention to quality and rigour. A strength of the study was that sample included 
women who had experienced a PPH following a vaginal, assisted or caesarean delivery method, 
which has often been an exclusion criteria in previous qualitative PPH studies. The views of 
women who had experienced a ‘moderate’ PPH ranging from 1500-4500ml were also included, 
highlighting a variety of medical severity and physical and psychological impact. To date, this is 
the first study to explore women’s experience of having a PPH and enrolling in research during 
this time. 
 
A limitation of the sample is that only women who had consented to OBS2 and had expressed an 
interest in future PPH studies were able to be contacted. Thus, the voices of those who chose not 
to consent and those who did consent but did not wish to take part in follow up research are 
missing. From those eligible, only a third were captured and no legal representative took part. 
Data collection stopped following sample adequacy, as described in the method. The researcher 
used a convenience sampling technique and as such it is acknowledged that the sample is unlikely 
to be representative of the population being studied, as typically they include small numbers of 
underrepresented sociodemographic subgroup (65). This is evident in this study, which was 
dominated by participants who were of White British ethnic background and who lived in the least 
deprived areas in Wales. Demographics such as socioeconomic status and education level were 
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not collected by the original trial, however the researcher has been able to estimate these using 
participant postcodes and the Welsh index for multiple deprivation. Several of the women 
interviewed appeared to have an interest in medical research and a strong birth narrative due to 
multiple complications which highlights a further potential sampling bias. Interviews took place 
between 6-18 months’ post birth and therefore the potential for recall bias is acknowledged, 
although research suggests women have good recollection of childbirth experiences (66).  
 
The researcher attended specialist teaching on qualitative methodology, had in-depth discussions 
with trial unit researchers experienced in applying framework analysis in a clinical health domain 
and accessed relevant literature. A significant benefit of using framework analysis is that it 
provides a clear audit trail, particularly during the stages of data management and analysis. The 
third author, a researcher with expertise in clinical health psychology and framework analysis 
double coded 15% of the transcripts, this was to check the coherence and credibility of the 
developing thematic framework. During the indexing, charting and interpretation stages, the 
researcher utilised supervision to check the credibility of the structure and coherence of codes and 
subsequent themes and sub-themes. The first author kept a reflexive diary, notes and memos 
during the research process which was used to acknowledge the researcher’s own motivations, 
beliefs, values and preconceptions that may influence the direction of the project. In addition, the 
researcher bracketed interviews to limit subjectivity. The aim was not to abandon assumptions 
altogether, but to prevent them from imposing on the data (64,67) to help “see and describe the 
phenomenon” (68). The advantage of bracketing is that researchers spend time “trying to 
understand the effects of one’s experiences rather than engaging in futile attempts to eliminate 
them” (64, 69). 
 
Conclusions 
Women’s views of the acceptability of consenting to research during a PPH are contingent on 
experiences of the birth, the PPH and the consent interaction. The findings highlight the 
importance of understanding the complex interplay of individual, interpersonal and systemic 
factors that underpin women’s obstetric emergency experiences and how this informs views on 
obstetric emergency research. The findings of this study can be used to inform future research 
protocols and clinical practice.  
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Paper 3: Critical reflection 	
 
Paper 3 evaluates the strengths and limitations of both paper 1 and paper 2. It also highlights 
implications for clinical practice and future research. 
 
Word Count: 8,000 
 
In paper three I critically reflect on elements of my research as reported in paper one and two as 
well as the research process as a whole. I discuss the implications of the research for clinical 
practice and the relevance to and role of clinical psychology in these fields. I also consider and 
reflect on the personal and professional competencies developed during this process.  
 
Personal Context 
Prior to starting the Doctorate of Clinical Psychology (DClinPsych), I identified as a clinician first 
and foremost. I had limited research experience which entailed conducting service development 
projects, audits and literature reviews. A key competency I wanted to develop during training was 
to enhance my research skills and engage in research that was meaningful. As such I was keen to 
be part of a research project emanating from a clinical trials unit and all the complexities and 
challenges that are embedded in this system.  
 
Regarding the topic of consent, I have worked clinically within child, forensic and inpatient 
settings where an individual’s autonomy to make every day decisions has been restricted for legal 
reasons such as detention under the mental health act, ministry of justice orders and criminal 
convictions. Working as a clinician within these settings, which were most commonly dominated 
by the medical model, I developed a position of wanting to promote shared health care decision 
making wherever possible within the bounds that the context allowed.  
 
My clinical experience prior to training had all been in mental health settings and I felt it was 
important to gain competencies working as a clinician and researcher in a medical health setting. 
Following a placement in child health and development I developed an interest in working with 
medical disciplines to deliver shared care. I became interested in the disparity between the 
approaches taken by psychologists and medical staff to the discussions and involvement of key 
stakeholders in care decisions. It reminded me of the consent dilemmas I witnessed within mental 
health settings. 
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I sought to conduct research that originated from a clinical research dilemma such as consent, 
driven by policy and practice rather than theory. Following a discussion with the second author of 
paper one and two, a researcher within the clinical trials unit, an opportunity arose to become part 
of the OBS2 trial. I was drawn to the topic because of the clinical health setting, the organisational 
context of the research and because of the opportunity to interview individuals in depth using a 
qualitative approach about their consent-gaining experience, to inform future research and clinical 
processes.  
 
The Systematic review 
Developing the question 
I was clear that I wanted to explore patients lived experience of consenting to research during a 
life-threatening medical emergency. On conducting a scoping review, it looked as though there 
was substantial literature, particularly in the last 10 years. However, after looking at it more 
closely it was evident that the up-to-date research used a mix between life-threatening and non-
life threatening emergency department samples. In addition, I had planned to conduct a qualitative 
synthesis but after the scoping search it was clear that researchers had used mixed-method trials 
to capture quantitatively and qualitatively meaningful data. Popularity of qualitative synthesis has 
increased utilisation of mixed method reviews (1). As such I chose to include mixed-method 
studies, but focused on the qualitative element of these studies. During the paper review stage, it 
was clear that there would only be a small sample that fitted the review criteria. 
 
Literature search and criterion 
 
Within the time parameters of the thesis, I aimed to conduct an ‘exhaustive’ review using a 
systematic and explicit strategy: predefined subject headings and key words (2, 3). I use the term 
exhaustive rather than comprehensive in line with Booth’s conceptualisation that exhaustive 
“conveys the finite nature of resources (e.g. searcher time, money, and access to databases; time 
to sift)” (2). I feel that this term corresponds with the process of conducting a thesis, as part of the 
DClinPsych e.g. alongside clinical placements and academic obligations. Although there is no 
consensus about whether comprehensive or theoretical sampling should take place in a qualitative 
evidence synthesis (4); I decided against theoretical sampling for several reasons. Due to the 
nature of the review question and intended purpose: to explore stakeholder’s views to inform 
policy and guidance, I decided that it was important to conduct a search that sampled all the 
available studies in the topic area. Theoretical sampling in qualitative evidence synthesis has been 
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criticised for aiding “subjective decision-making” (5) and risking omission of studies that may be 
important to the phenomenon of interest.  
 
I did consider the options of using a specific search tool such as ‘PICOS’ (population, intervention, 
comparison, outcomes and study design) or ‘SPIDER’ (sample, phenomenon of interest, design, 
evaluation, research type) to develop a targeted search strategy (6). However, for several reasons 
I decided to use only two components of the search tool. Due to the poor indexing of qualitative 
studies or methods and limited use of keywords (6) I decided not to use search terms representing 
‘study design’ as I did not want to risk missing relevant studies. In addition, I chose not to use 
search terms representing the concept of ‘views, perceptions, experiences’ due to the extent of 
available options.  Although intended as a search framework, I found PICOS very useful for 
clarifying the study inclusion and exclusion criteria and used it as a checklist whilst reviewing the 
studies. I developed the search terms and overall strategy in collaboration with a specialist medical 
librarian with experience in conducting medical systematic reviews. As a systematic review 
novice, I found their guidance invaluable as it enabled efficient navigation of the databases and 
enhanced my understanding of developing and adjusting search terms according to desired 
specificity and sensitivity. Research has shown that the inclusion of a librarian correlates with 
higher quality reported search strategies in general internal medicine systematic reviews (7). As 
such I believe the guidance of an experienced librarian increased the validity and reliability and 
therefore the overall rigour of the systematic search and a skill-set for the future.  
 
Application of critical appraisal tools in qualitative evidence synthesis 
 
Although widely regarded as an essential component of quantitative systematic review of trials 
(8), the application and value of critical appraisal in qualitative evidence review and synthesis 
continues to be a topic of debate (9). Those arguing against the usefulness of critical appraisal in 
qualitative evidence syntheses highlight that qualitative studies rated as having good 
methodological rigour do not necessarily translate in to in-depth synthesis findings (10, 11). 
Within the last two decades, there has been a trend towards critically appraising primary studies 
within qualitative evidence syntheses to highlight validity and reliability and inform subsequent 
secondary analysis. As such, there has been a transition from debating the value of critical 
appraisal in qualitative reviews to debating what criteria to use (9, 12). In accordance with 
recommendations from The Cochrane Collaboration Qualitative Implementation and 
Management Group (CQIMG, (13) I used critical appraisal tools to assess the quality of the 
studies.  
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Rationale for chosen tools 
After researching critical appraisal tools for qualitative and mixed-method studies, I decided on 
using the Critical Appraisal Skills Programme (CASP qualitative, (14)) and Mixed Method 
Assessment Tool (MMAT, (15)). Although there remains no consensus on the quality criteria of 
mixed-method studies (16), I chose to use the MMAT as the author was transparent about the 
tools theoretical development: influenced by the work of Ian Hacking a social constructionist and 
the outcome of a review of several systematic mixed studies reviews (17). It was also the only 
tool that explicitly incorporated a section on the integration of mixed method components and 
addressed questions such as 1) is the mixed method design appropriate? 2) are the qualitative and 
quantitative parts integrated? and 3) are the limitations about this design discussed? Consideration 
was given to using the Crowe Critical Appraisal Tool (CCAT, (18)) instead of two separate tools, 
however in comparison to the MMAT and the CASP, the CCAT was more time demanding and I 
felt it was important to have specific qualitative and mixed method review tools rather than a 
generic tool (19).  
 
Subjectivity of quality assessment 
With no previous experience using an established critical appraisal tools, I was struck by the 
apparent subjectivity of the assessment questions in both the CASP and MMAT despite author 
guidelines.  Prior to this work I had made an implicit assumption that critical appraisal tools would 
be standardised and definitive yet I was left questioning my assessment of the studies. The process 
highlighted to me the importance of having a second reviewer and discussing and justifying 
quality decisions and I also developed an understanding of the rationale for a team of reviewers 
within large scale systematic reviews.  
 
Bias and limitation in the studies 
Whilst conducting the critical appraisal process, I became aware of the difficulties of assessing 
the quality of a study based on only its reporting in a published article. Poor reporting of qualitative 
studies is prevalent (9) and this compromises the quality assessment. It prompted me to consider 
the influence and bias of the diversity of journal reporting guidelines and word count on 
assessment of quality within and across studies (9). I was particularly frustrated by the lack of 
reflexive statements in the articles: negating written consideration of the influence and position of 
the researchers within the research process. This reiterates Franzel et al., findings that reflexivity 
is often not reported in published papers (20). It was apparent that many of the studies had not 
used qualitative research reporting guidelines (21), developed to encourage the reporting of details 
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such as reflexivity. I decided to only include studies which were published in a peer-review journal 
and in the English Language, despite coming across studies of interest that were part of conference 
papers which highlights a potential limitation due to publication bias. 
 
Sensitivity analyses 
The decision to include or exclude studies from qualitative evidence syntheses following 
assessment of quality continues to be deliberated (9). Exclusion of studies can seem arbitrary 
without justification. Tong et al., (22) reiterate the importance of stipulating reasons for exclusion 
or weighing and statement of thresholds. I decided not to exclude studies based on quality 
assessment but instead highlight the contribution of the papers to the thematic findings. I took this 
decision after reading a number of articles that explored the risk and benefits of excluding or 
weighting poor quality studies (2, 9). However, I could have gone one step further and conducted 
a sensitivity analysis. Sensitivity analysis weights studies rather than excludes and as such no 
information is removed from the synthesis but rather a critical context is provided for the reader.  
 
Rationale for thematic synthesis 
I was overwhelmed by the diversity of qualitative synthesis approaches, a common complaint for 
researchers conducting qualitative reviews (23). However, after reviewing several approaches 
including meta-synthesis (24); narrative synthesis; and framework synthesis (25), I decided that 
thematic synthesis, as described by Thomas and Harden (26) was the best fit for the research 
objectives. Thomas and Harden developed the approach for use in health promotion and public 
heath, to explore stakeholder’s views on the appropriateness and acceptability of specific health 
interventions to inform practice and policy. I believed this corresponded with the objectives of the 
systematic review question which were two-fold. The first was to identify individuals lived 
experience and views of consenting to research in a life-threatening emergency setting and the 
second was to use this information to consider improvements to the way in which research consent 
pathways are implemented in emergency clinical practice. A further rationale for using thematic 
synthesis was that it is considered “epistemology-neutral” (27), as such it can be applied to 
aggregative, configurative and mixed approaches to synthesis (28). I believe that this review is 
not aligned to a specific ontological or epistemological position.  
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Implications for practice 
Reflections on professional position: clinical equipoise vs. expert position  
Within a randomised controlled trial (RCT) design, clinicians are required to communicate to the 
patient a position of clinical equipoise, therefore relinquishing the expert position. It is important 
for clinicians to recognise the influence their own beliefs and feelings on approach and engagement 
in trial recruitment. Specifically, beliefs centred on the effectiveness of the treatment interventions 
in question (therapeutic optimism; (29)) and how they relate and respond to the societal expectation 
of being an expert and consequently comfort or discomfort with upholding the position of ‘not-
knowing’ in an RCT. Not only is it confusing for patients but professionals themselves who are 
ethically bound by two conflicting medical paradigms (30). 
 
Professionals appear to overestimate patient’s understanding of medical interventions and models 
of research; as such patients struggle to understand the information given. A patient’s ability to 
comprehend the research information is dependent on reading level, age and level of health literacy 
but also external factors such as the content of the information provided and the recruiting 
professionals communication style. Information sheets should be accessible to patients in 
populations that are hard to reach or considered vulnerable (e.g. patients who have hearing, sight 
or speech difficulties, are unable to read or write, speak a different language, have a mental health 
or cognitive difficulty) to promote inclusivity and prevent findings bias because of poor 
accessibility. Information sheets and consent forms should be specific to research studies and target 
populations. Forms should be succinct and provide lay explanations of research and medical terms 
to promote patient knowledge and understanding and counter low health literacy. 
 
Link to systems theory 
The findings from the synthesis highlighted patients experience of consenting to research during a 
medical emergency appeared to be influenced by individual and systemic contextual factors: 
patients medical condition, patient’s belief and value set, patients support network, interaction with 
professionals, the emergency context and cultural expectations (e.g. perceived role of doctors and 
the role of research in medicine). I view the findings as relating to systems theory, an 
interdisciplinary study of systems. Systems theory is based on the premise that a system is an entity 
with hierarchical, interrelated and interdependent networks, with increasing complexity, which are 
defined by boundaries and is more than the sum of its parts (31). Systems thinking offers an 
alternative to reductionist thinking which prioritises individual components, linear connections and 
often negates the relevance of context (31). To understand a system, it is important to consider the 
77 
intrapersonal, interpersonal and macrosystemic factors over time (32). Systems theory can be used 
to develop an understanding of certain behaviours such as informed consent decisions in 
emergency settings, in the context of the ecological environment e.g. professional-patient 
interaction and communication, medical emergency context, cultural and society norms and values 
on medical research (32). This can ensure that consent processes are considered within the context 
which can enable efficient problem-solving and implementation of relevant interventions.   
 
The Empirical paper 
 
Joining the trials unit and project 
 
The prospect of joining a well-established clinical trials unit was both exciting and daunting. I was 
mindful that I was joining a team of experienced researchers and individuals who had or were 
currently conducting PhD’s and were accustomed to the structure, terminology, policies and 
procedures of a clinical trials unit. Initially I found it difficult to explain the parameters of the thesis 
within the DClinPsych and how it sits alongside clinical and academic demands. It was assumed 
at times that I was completing a PhD and that my time was dedicated solely to the research project. 
I found I had to clarify my role, the time constraints of the DClinPsych and the competencies I 
needed to demonstrate in the thesis. At times, I became overwhelmed by the responsibility and task 
of balancing the requirements of the DClinPsych thesis and the requirements and responsibilities 
for delivering the qualitative component OBS2 trial.  
 
I was aware of my position within the trials unit hierarchy which, compounded with being a novice 
researcher, made me question what I could offer the OBS2 project and trials unit. The project was 
based in general health setting, an area I have little experience of clinically. Supervision with my 
academic research supervisor was invaluable whilst negotiating this new system. The fact that my 
supervisor was both a Clinical Psychologist and an experienced trials unit researcher enabled open 
discussions about the complexities of transitioning to and from the different roles or ‘hats’ as we 
labelled the phenomenon. We discussed dilemmas such as clarifying my role and position in the 
project; identifying the practical support network within the project; and developing competencies 
in participant recruitment, conducting research interviews and qualitative data analysis. My 
supervisor helped me reflect on my established meta-competencies and the transferable nature of 
these competencies to medical and trial settings. We discussed how being a psychologist rather 
than a medical professional enabled me to take a ‘naïve/not-knowing’ position within the project 
and offer a psychological perspective on medical processes.  
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The OBS2 trial was categorised as a Clinical Trial of an Investigational Medicinal Product 
(CTIMP): a study that looks at the safety or efficacy of a medicine, food item, placebo in humans 
(33,34). Learning the terminology and guidelines associated with a CTIMP trial was a learning 
curve, and completing Good Clinical Practice (GCP) training through the National Institute for 
Health Research was invaluable in generating an understanding of and the reasons for specific 
OBS2 trial processes. It was vital that I understood the original OBS2 trial protocol to enable 
successful and purposeful interviews with women who had consented to this trial.  
 
Informed consent 
 
Informed consent is a legal obligation based on ethical theories of personal autonomy and self-
determination (35). However, the interpretation and implementation of informed consent in clinical 
practice remains complex. Several clinical models of informed consent have been proposed to 
bridge the gap between ethical theories and clinical practice (36).  
 
Clinical models of informed consent 
Models can be divided in to those that focus on informed consent as an ‘event’ and those that focus 
on it as a ‘process’. Wear’s (37) event model of consent is focused on professional’s disclosure of 
risk information and the actual documentation of the patient’s decision to consent. The role of the 
patient in the event model is to use the information disclosed by the professional to make a 
judgement about treatment preference based on their values. There is no acknowledgement of 
transactional communication between the professional and patient nor the relational nature of the 
encounter the influence this may have on a patient’s decision-making ability. It adheres to the legal 
obligation of informed consent rather than ethical ideals of respect for personal autonomy.   
 
The process model, devised by Lidz et al. (38), stipulates two principles before the consent process 
can be conducted. The first is that the roles of both the professional and patient in the consent 
transaction need to be defined, with an emphasis on the need for information-sharing rather than 
information disclosure conversations (36). The second is acknowledging that health professionals 
and patients have different beliefs, values and understanding about medical treatment, risks and 
perceived responsibility for treatment decision-making. Lidz et al. suggest that these principles 
should underpin and inform the information-sharing and decision-making process between 
professional and patient (38). Faden and Beauchamp (35) criticise this model for suggesting that 
informed consent can a shared-decision. They emphasise the need for the decision to be made 
autonomously and voluntarily by the patient. 
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The final model to be discussed is Katz’s ‘conversation model of interaction’ (39) which is less 
prescriptive of the content of the conversation and more reflective about the meaning or intention 
of the dialogue. Self-determination and personal autonomy principles underpin this theory. Katz’s 
defines self-determination as an individual’s right to make a choice free from external pressure and 
personal autonomy as the psychological capacity of the individual to exercise this right to self-
determination. Therefore, he considers self-determination as two interlinked components: 
‘internal’ and ‘external’. The external component is the patient’s actual choice and the internal 
component of self-determination is the patient’s capacity to “reflect, choose and act” (39) with an 
awareness of individual and systemic influences. Both the internal and external components should 
be given equal value. Professionals should engage in information-sharing conversations to discuss 
not only the details (benefits and risks) of the treatment but also the influence of psychological and 
systemic factors on decision-making to enable the patient to exercise their right to make an 
informed choice. Katz’s model aims to increase professional’s conscious awareness of the ethical 
principles of informed consent processes in clinical practice rather than consent being seen as 
simply a legal and procedural event (36). 
 
The event model focuses on the legal role of the professional to disclose all relevant information 
about treatment options and risks rather than the transactional nature of the dialogue. It therefore 
places more responsibility on the professional and the patient holds a passive role until the point in 
which the decision is made. The conversation and process models on the other hand, emphasise 
the need for the professional and patient to engage in an information-sharing dialogue, founded on 
exploration of values, beliefs and expectations, prior to patient’s making decisions regarding 
treatment.  
 
Although these models have been developed for implementation in clinical practice, the same 
principles apply in the context of consent for research. The process of consent to partake in research 
trials, like in standard clinical practice, is often focused on written documentation or proof that the 
patient consented. However, it is necessary for researchers and professionals to recognise informed 
consent as a process, a verbal conversation between professional-patient that shares information 
on ideas and values, and not just an event, a signed form (40).  
 
Professional guidelines on the ethics of consent 
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It is unsurprising that health professionals, even those more senior, may struggle to understand 
what an informed consent process entails in clinical and research practice given that professional 
guidelines such as the Nursing Midwifery Council (NMC), General Medical Council (GMC) and 
British Psychological Society (BPS) provide similar but limited accounts of informed consent 
processes in clinical practice and research. They denote the importance of information-giving 
rather than information-sharing: be given “the information they want or need in order to decide 
whether to take part in research” (41, 42) and “…ensure that clients, particularly children and 
vulnerable adults, are given ample opportunity to understand the nature, purpose, and anticipated 
consequences of any professional services or research participation, so that they may give informed 
consent to the extent that their capabilities allow” (43, 44). 
 
Why explore stakeholder’s experience of the consent-gaining process in research?  
 
Informed consent is a vital component of ethical requirements to undertake research. Yet, consent-
gaining processes are often negated or minimised in reporting’s of studies (45) and therefore 
avoidant of interpretation, suggesting tokenistic interest in this complex and integral concept. 
Interest has developed over the last decade in understanding individuals’ experiences and views of 
the informed consent process (e.g. acceptability and professional-patient communication and 
interaction) in clinical and research practice. By exploring individuals experience of consenting to 
a research trial, consent becomes a topic of analysis. 
 
The topic of consent has specific context in Wales given the recent change to use a ‘soft opt-out’ 
for organ donation under The Human Transplantation (Wales) Act 2015. The soft opt-out works 
on the premise of 'deemed consent': if an individual has not registered a clear organ donation 
decision (opt-in or opt-out), they will be treated as having no objection to being an organ donor. 
(46). 
 
 
Framework analysis 
 
Framework analysis was developed in the 1980’s by Jane Ritchie and Liz Spencer, researchers in 
the Qualitative Research Unit at the National Centre for Social Research (NCSR) for use in social 
policy research. However, the approach is now regularly used in health research (47) and 
psychology (48). Framework analysis is based on a case and theme approach using five inter-
connected stages: familiarisation, indexing, charting, mapping and interpretation. The trademark 
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of framework analysis is the matrix-based format (49), which enables researchers to systematically 
reduce and summarise data whilst retaining links to the primary textual narrative (49). The inter-
connected stages also allow the researcher to move back and forth across the data iteratively until 
a coherent account emerges (50). The approach enables a transparent audit trial of the entire process 
but specifically the interpretation stage, which involves thematic analysis, development of 
typologies and explanatory analysis.  
 
Framework analysis has been referred to as both a method and an analytical tool by the authors 
through the stages of development (49-51). The latter is the author’s most up-to-date description 
of the approach. As such I consider framework analysis as a tool to systematically code and manage 
qualitative data that aims to generate themes (47).  
 
Rationale for using framework analysis 
 
When I joined the OBS2 qualitative study, the ethics had been written and accepted and as such 
the choice of qualitative method had been decided. Having said this, I had subsequent opportunities 
in the ethical amendment for the qualitative sub-study to change the methodology however I 
believed that framework approach fitted with the design, scope and objectives of the research. The 
study utilised semi-structured interviews that produced verbatim text with “fractured discourse” 
(49) which framework is helpful in managing. Regarding scope, there was the potential for a large 
quantity of qualitative data because 42 women had expressed interest in being part of future PPH 
studies and it was unclear how many would consent to be part of the OBS2 qualitative study. 
Further to this, the objectives of the OBS2 qualitative study were two-fold: contextual and 
evaluative (formative) and as such suitable for the application of framework analysis. A contextual 
research question aims to explore and describe participants' understanding and interpretations of 
social phenomena in a way that captures their inherent nature. Formative evaluations are designed 
to provide information that will help to change or improve a programme or policy, such as protocols 
for research (50). OBS2 aimed to contextualise women’s experience of the consent process within 
an emergency obstetric setting and evaluate the acceptability of this process to inform consent 
protocol in future PPH trials. 
 
Developing the interview schedule 
The premise of the questions in the protocol, developed in collaboration with a maternity lay 
adviser was expanded in to an interview schedule. The interview schedule was developed after 
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conducting scoping searches of relevant and up-to-date literature and discussions with both 
supervisors. 
 
Participant information sheet and consent-gaining process 
From the original OBS2 consenting process there was a group of women who had also expressed 
interest in being part of future PPH studies including talking about their experience of OBS2. They 
were initially approached via email by the research midwife on my behalf. The email gave details 
of the qualitative study and provided a further opportunity for women to opt-out of being contacted. 
After 2 weeks, I contacted the women by phone.  
 
Whilst writing-up the empirical paper and going through a draft with my course supervisor we 
realised that although I had gone through the participant information sheet in detail with the women 
on the phone and then again before the start of the interview and they had given written consent, I 
had breached the OBS2 protocol because I had not sent out the participant information sheet in the 
post prior to the interview. I was mortified by my mistake and very much felt like a novice 
researcher. The senior trials manager and other researchers involved in OBS2 were notified and a 
report was sent to the quality assurance team within the trials unit to assess the severity of the 
breach. Quality assurance considered the error as a low risk breach and stipulated that a protocol 
non-compliance form would need to be completed and it should be considered as an opportunity 
to learn lessons and prevent future breaches.  
 
I have reflected on this over and over, and I remain unclear why I did not follow this part of the 
protocol but followed everything else. The only reflection I have is that having spoken to the 
women on the phone, conversed about the details of the study and participation requirements and 
explained that I would go through information again when we met, I believed I had provided the 
necessary information for them to agree to meet and then decide whether to go ahead with the 
interview. I guess in a sense I transitioned into a clinician during this time rather than a researcher, 
my focus was on meeting the women in person. I truly believe that this breach did not impact on 
the women’s ability to make an informed choice to take part in the qualitative study. There were 
numerous stages in the process that enabled the women to opt-out and when we met for the 
interview, we spent time engaging in information sharing and discussion, reviewing the 
information sheet and their right to stop the interview at any point. This was also reiterated when 
the recording started.  
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It was important for me to be open and honest about this in the thesis because it was a huge learning 
curve and impacted on my development as a clinician-researcher. I feel it is important to recognise, 
take ownership, reflect and learn from mistakes to develop personally and professionally. 
 
Clinician vs. researcher role: conducting interviews  
Some professionals have criticised qualitative research for being “saturated with ethical issues” 
(52) due to the degree of researcher-participant interaction (53). This, coupled with empirical 
evidence that barriers to acting ethically occur when professionals wear “too many hats” (53), made 
me continually reflect on and discuss in supervision ethical constructs such as confidentiality, 
consent, dual-role, and the influence of politics and power (54). A central topic of conversation in 
supervision was the similarities and difference in my role as a qualitative researcher conducting 
research interviews and as a trainee clinical psychologist conducting therapeutic interviews in 
clinical practice. I was mindful of the sensitive nature of asking women to talk about their 
experiences of a having a PPH and the possible affect that this may evoke. As a clinician, I regularly 
interact and support individuals who are emotionally distressed and as such this was something I 
felt competent in anticipating and managing sensitively whilst still maintaining the role and 
boundaries of a researcher. As it turned out no woman became acutely distressed whilst discussing 
their PPH experience and therefore I did not experience having to signpost them to support rather 
than offer guidance as a clinician would do. I am mindful that had I have experienced this I may 
have felt differently in the moment.  
 
I believe the fact that I was external to the clinical care, something I was clear to state at the start 
of the interview, aided more honest reflection from the women on experiences of obstetric care and 
interaction with professionals. Additionally, my position as a non-medical professional, external 
to general medical health services enabled me to take a position of naivety during the interviews. I 
asked for clarification on medical terminology used by the women, in doing so exploring and 
gaining a sense of each women’s understanding of medical terms. At times, some of the women 
appeared to look to me for answers if they couldn’t remember the exact name of a medication they 
were given or a procedure that took place. In the moment, I was aware that even though I did not 
know the answers, I was drawn to wanting to give suggestions and problem-solve. As such this 
was something I remained mindful of so as not to enter the role of rescuer and disrupt the woman’s 
narrative. 
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During the interviews, there was a narrative that women’s emotional wellbeing was negated 
following the PPH in favour of a focus on physical wellbeing. I found myself becoming frustrated 
that women had experienced a lack of emotional support, particularly when some women 
commented on how they had found taking part in the interview and talking about their experiences 
helpful in processing their feelings and memories of the events. I was aware of this rising affect 
during the interviews and spent time processing these feelings in my reflective diary after it 
occurred and within supervision. I came to realise that my background in mental health meant that 
I was used to being part of systems that prioritise emotional wellbeing and where staff are trained 
and feel comfortable initiating discussions about the impact of life events on psychosocial 
wellbeing. After every interview, I wrote an entry in my reflective diary to reflect on process (e.g. 
attunement and interaction with the women, any children or partners; bias/assumptions that 
occurred; emotional impact of hearing about their experience) and procedural (written consent 
process, negotiating the recording device; flow of questions) parts of the interview. 
 
Data analysis 
I was both drawn and daunted by framework analysis. I was drawn to it because I felt it offered a 
flexible structure and a transparent process that guided the management of the data to aid the 
interpretation process. However, after reading research articles that had applied framework analysis 
in practice I became daunted. Researchers had identified difficulties in developing the thematic 
framework in stage one and knowing when to move through the stages. In addition, many studies 
were conducted by multiple researchers who found the approach time consuming. At this point I 
was very aware of the fact that I was a novice qualitative researcher, having conducted a small 
number of thematic analysis projects. It was important at this point that I sought supervision from 
my trials unit supervisor, an experienced qualitative researcher who has applied framework 
analysis in practice. Supervision enabled me to reflect on my novice position but also develop 
competencies through data analysis practice sessions using NVivo PRO. I had never used NVivo 
before but I was keen to utilise this platform because of its built-in framework matrix functions. It 
was all a learning curve for me, and I took every opportunity to meet and talk to other qualitative 
researchers in the trials unit that had applied framework analysis in practice. 
 
I found the data analysis very labour intensive. At times, it felt like it was an endless process. 
Framework analysis has several ‘data management’ stages and this took a substantial amount of 
time. However, the iterative nature of the thematic framework enabled me to work methodically 
back and forth within and across interviews without worrying that it was a fixed, definite 
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framework. When it came to the mapping and interpretation stage I felt completely immersed in 
the data and had developed ideas about patterns within and across women’s narratives of the 
consent process. I realised the benefit of having spent a considerable amount of time in organising 
the data (stages 1-3) was that I had been interpreting the data long before the final stage through 
use of memos, notes and coding.   
 
OBS2 extra qualitative components 
 
The OBS2 qualitative study protocol documented three sub-sections: interviews with women who 
had consented to the OBS2 trial; asynchronous focus group with health care professionals 
involved in gaining consent during the OBS2 trial and a face-to-face focus group with community 
midwives.  
 
Community midwives focus group 
The rationale for interviewing the community midwives was to explore how they experienced 
discussing the antenatal OBS2 trial information with women on their caseload. Time was taken to 
develop the midwives focus group interview schedule with a senior midwife and researcher based 
within the trials unit (see Appendix 8). We wanted to focus on finding out the barriers to discussing 
the antenatal information with the women and midwives comfort and view on incorporating 
discussions about research trials in clinical consultations. I contacted a senior midwife who was a 
team leader for one of the community teams and despite OBS2 having finished the year before 
she was very positive about supporting me to hold a focus group. The focus group was arranged 
on three occasions between December 2016-March 2017 however it was cancelled each time. On 
the first occasion, it was cancelled due to my sickness and on the other two occasions due to the 
midwives needing to prioritise clinical caseload management because of high sickness in the 
teams. I was disappointed that I was unable to conduct this focus group as I felt it would had 
provided rich feedback on professionals view of the need and usefulness of antenatal trial 
information which could have been analysed alongside the women’s feedback. 
 
Consent-gaining health professionals focus group 
Asynchronous methods use a discussion forum to enable researchers and participants to see one 
another’s questions and answers and respond over a set timeframe. Initially OBS2 was going to 
be a multi-centre trial however only Cardiff contributed to the trial. As such I felt the asynchronous 
methods no longer suited the design of the trial. In addition, I was aware that the parent trial had 
been conducted over a year ago and therefore healthcare professionals may not have clear 
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recollection of consent-gaining interactions. Immersion in the project enabled a different 
perspective to those who were managerially involved and as such I requested that I make a 
substantial amendment to the protocol to change the focus group from asynchronous to face-to-
face. My rationale was that I believed the opportunity for professionals to interact and converse 
with one another face-to-face about the topic may promote rich discussion and prompt memories. 
Following ethics approval, I met with a consultant obstetrician who was part of the OBS2 parent 
trial and we discussed how best to contact doctors who had been involved in the consent-gaining 
process. Many doctors had moved to different hospitals as part of rotation in their medical training. 
I attempted to meet again with the obstetrician to develop interview questions but unfortunately, 
we could not find a mutual time to meet within the given time frame. The reality that the parent 
trial had been completed over a year ago, and health professionals were now involved in new 
clinical trials, impeded any progress or motivation in conducting the qualitative study within the 
time frame. 
 
Rationale for journal  
 
In consultation with the trials unit, I decided to write-up the empirical study for publication in the 
BMC pregnancy and childbirth journal. I was clear from the start that I wanted the study findings 
to be accessible to clinicians working in the specialty of obstetrics to help inform future clinical 
and research practice. I could have chosen a medical ethics journal, however I felt that this would 
have reduced the accessibility to every day clinicians.  
 
Dissemination plan 
 
As part of the qualitative dissemination plan, I offered to send a summary of the findings to the 
women who participated in the interviews. Those women who were interested in receiving this 
information will be sent the summary in Summer 2017. The OBS2 team are putting together an 
application for a larger randomised trial to develop their work (OBS3) and so I will be presenting 
the results of the research to them. Specifically, the findings of the qualitative study were used to 
inform the interview schedule for the OBS3 protocol. The trials unit has a newsletter and members 
of the unit often use a blog to disseminate the headlines of work that has recently been published. 
I will need to think with the wider OBS2 team about how to disseminate the information to the 
practitioners in the clinical service.  
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Implications for clinical and research practice 
 
Informed consent: a process and an event 
Both the review and empirical study highlighted consent as both a dynamic, relational process 
between professional and patient and a legal event of signing documentation. Informed consent 
as process, as advocated by Lidz et al. and Katz (38, 39)  has parallels to shared-decision making 
in clinical practice. Yet consent as solely an event, is heavily employed by health professionals in 
clinical and research settings (55). It is understandable that during a medical emergency, 
especially an obstetric emergency where care is divided between the woman and her baby, that 
professionals may focus on consent as an event: the legalities of disclosing information and asking 
for a decision. However, it is important for medical professionals to recognise that there is a need 
to engage in information sharing, discussion, support and validation so that patients might feel 
better able to decide on research enrolment during this distressing time. In addition, professionals 
are not obligated to understand the ethical theory underpinning informed consent (56). However 
it may help professionals to understand the ethics and values base such as self-determination, in 
order to implement consent processes in a more patient-centred and meaningful way in clinical 
and research practice (36): treating patients as unique individuals (57) and considering the patients 
values, views and circumstances (58). 
 
Relevance to and the role of Clinical psychologists 
 
Clinical psychologists have extensive academic, research and clinical experience and are well 
positioned to hold senior leadership roles in healthcare. Clinical psychologists have meta-
competencies (59) that add value to patient-centred care pathways, developing effective team-
working and leading strategic development across research and clinical settings such as medicine 
and mental health (60). Clinical psychologists can promote the importance of collaboration in the 
professional-patient relationship and the impact of this on health outcomes (61). 
 
Role in research 
Clinical psychologists are scientist-practitioners (59) and are therefore competent in conducting 
research, providing therapeutic interventions and integrating the two domains. Skills in building 
rapport with individuals and delivering important information effectively can be useful when 
transitioning between clinician-researcher roles. Clinical psychologists, along with lay people, can 
offer different perspectives and suggestions to pure researchers, when developing research 
questions, ethics, protocols, stakeholder information sheets and consent pathways. Clinical 
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psychologists are skilled in collaboratively working with stakeholders in a multitude of complex 
settings and can therefore offer guidance for conducting research in hard-to-reach or vulnerable 
populations within medical (e.g. emergency trauma, palliative care, paediatrics) and mental health 
(learning disabilities, older adults, looked after children) services. 
 
Medical settings 
 
Clinical psychologists are increasingly employed in medical settings due to the recognition that 
patients should receive holistic and biopsychosocial care (62, 63). Clinical psychologists can offer 
a valuable psychosocial perspective, such as providing a systemic and relational context, that can 
complement the medical model. In addition, Clinical psychologists can be both embedded within 
a multi-disciplinary medical team or provide input into and across specialities. Ethical and 
practical challenges remain in the professional-patient process of ensuring informed consent for 
treatment in medical research trials and practice. Clinical psychologists can open dialogue with 
other medical professionals about the complexities of informed consent in both standard clinical 
practice and research trials and highlight the importance of the professional-patient relationship 
and communication in the informed consent process. Clinical psychologists can offer other health 
professionals training on the ethical theories of informed consent and a focus on consent as a 
relational process of information sharing and discussion rather than just a legal, procedural event 
based on disclosures of risks and signing a written document. They can also offer consultation 
and supervision for complex cases or consent dilemmas and promote psychological thinking 
drawing on formulation and theoretical skills and knowledge. Further to this, Clinical 
psychologists can be involved in strategic development, contributing or leading services and by 
consulting on clinical, research policies, procedures and more broadly government legislation. 
 
Obstetrics and perinatal settings 
  
There is increasing recognition of the value of employing clinical psychologists in obstetric and 
perinatal settings (64). Perinatal services are increasingly recognising the importance of 
psychological thinking and Clinical psychology leadership has been advocated in perinatal clinical 
guidelines such as National Institute (NICE) ‘Antenatal and Postnatal Mental Health guidance’ 
(65) and commissioning reports ‘guidance for commissioners of perinatal mental health services’ 
(66).  
 
Clinical psychologists can provide preventative evidence-based interventions to women and their 
families. They can also provide indirect psychological interventions such as consultation, training 
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and supervision to other health professionals working across the antenatal, intrapartum and 
postpartum community and hospital pathway. They can work across the connected services to 
provide continuity of care, champion integration of services and empower active engagement of 
stakeholders: a key priority for health commissioners (61). A key role of Clinical psychology 
could be bridging the gap between perinatal medical and mental health services. The profession 
can play a valuable role in increasing awareness about the risk of emotional distress or 
psychological trauma for both women and their partners, during and following birth complications 
such as PPH.  
 
Impact of the research on my practice 
 
I believe that this research has provided me with opportunities to develop both personally and 
professionally. Professionally I have developed specific research skills such as conducting 
systematic searches of databases, synthesising primary data, completing ethics applications, 
designing interview schedules, conducting interviews and conducting qualitative `data analysis. 
In addition, I experienced working as part of a clinical trials unit, interacting with experienced 
researchers, multiple clinical disciplines and stakeholders and adapting my language and 
communication style accordingly. I now have first-hand experience of conducting research 
focused on informing service delivery in the NHS, a goal I set at the start of training.  
 
The research also emphasised to me the importance of communication and rapport and 
information-sharing with stakeholders in clinical practice. It also gave me knowledge of the legal, 
philosophical and ethical underpinnings of the concept of informed consent of which I didn’t have 
a clear understanding of before. I plan to ensure that in therapeutic practice I engage more 
heartedly in consent conversations with stakeholders using principles and approaches from the 
process and conversation models of informed consent rather than perhaps.   
 
What I would have done differently  
 
With hindsight, if I had been able to be part of the development of the OBS2 qualitative study I 
would have suggested several changes to the protocol. The applied protocol stipulated that women 
in the study be sent out the written participant information sheet via post. I would have amended 
the protocol to state that the interviewer would ask the woman during the phone call how they 
would like to be sent the written participant information sheet (via post or email) in advance, thus 
bringing the woman in to the decision-making from the start. Enabling the women to choose how 
90 
they would like the written participant information sent to them prior to the interview promotes 
open dialogue and patient choice.  
 
In addition, I would have included the opportunity to discuss the thematic findings of the study 
with the women involved to enable respondent validity. I would have suggested that the main 
themes of the women’s interviews be used to provide context and case summaries for discussion 
within the community midwives focus group and the health professionals focus group. I would 
hope this would provide a platform to share and discuss women’s experiences with professionals 
to promote reflection on the consent-process from the professional’s perspective. Ideally, 
interviews with the women would have taken place closer to their birth experience. 
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Appendix 1: Submission guidelines for the International Journal of Emergency Medicine 
Reviews Criteria 
 
Reviews are a feature of the journal that may include, but are not limited to, the following 
types of articles: 
• systematic and substantial syntheses of specific research areas, 
• evaluations of progress in specified areas, 
• critical assessments with respect to issues 
within the scope of International Journal of Emergency Medicine. 
 
Preparing your manuscript 
Title page 
The title page should: 
• present a title that includes, if appropriate, the study design e.g.: 
o "A versus B in the treatment of C: a randomized controlled trial", "X is a 
risk factor for Y: a case control study", "What is the impact of factor X on 
subject Y: A systematic review". 
o or for non-clinical or non-research studies: a description of what the article 
reports. 
• list the full names, institutional addresses and email addresses for all authors: 
o if a collaboration group should be listed as an author, please list the Group 
name as an author. If you would like the names of the individual members 
of the Group to be searchable through their individual PubMed records, 
please include this information in the “Acknowledgements” section in 
accordance with the instructions below. 
• indicate the corresponding author. 
Abstract 
The abstract should not exceed 350 words and should be structured with a background, 
main body of the abstract and short conclusion. Please minimize the use of abbreviations 
and do not cite references in the abstract. 
Keywords 
Three to ten keywords representing the main content of the article. 
Background 
The Background section should explain the background to the article, its aims, a summary 
of a search of the existing literature and the issue under discussion. 
Main text 
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This should contain the body of the article, and may also be broken into subsections with 
short, informative headings. 
Conclusions 
This should state clearly the main conclusions and include an explanation of their 
relevance or importance to the field. 
Declarations 
List of abbreviations 
If abbreviations are used in the text they should be defined in the text at first use, and a list 
of abbreviations should be provided. 
Ethics approval and consent to participate 
Manuscripts reporting studies involving human participants, human data or human tissue 
must: 
• include a statement on ethics approval and consent (even where the need for 
approval was waived). 
• include the name of the ethics committee that approved the study and the 
committee’s reference number if appropriate. 
Studies involving animals must include a statement on ethics approval. 
See our editorial policies for more information. 
If your manuscript does not report on or involve the use of any animal or human data or 
tissue, this section is not applicable to your submission. Please state “Not applicable” in 
this section. 
 
Consent for publication 
If your manuscript contains any individual person’s data in any form, consent to publish 
must be obtained from that person, or in the case of children, their parent or legal guardian. 
All presentations of case reports must have consent to publish. You can use your 
institutional consent form or our consent form if you prefer. You should not send the form 
to us on submission, but we may request to see a copy at any stage (including after 
publication). 
If your manuscript does not contain any individual persons data, please state “Not 
applicable” in this section. 
 
Availability of data and materials 
For all journals, SpringerOpen strongly encourages all datasets on which the conclusions 
of the manuscript rely to be either deposited in publicly available repositories (where 
available and appropriate) or presented in the main paper or additional supporting files, in 
machine-readable format (such as spreadsheets rather than PDFs) whenever possible. 
Please see the list of recommended repositories in our editorial policies. 
For some journals, deposition of the data on which the conclusions of the manuscript rely 
is an absolute requirement. Please check the Criteria section for this article type (located 
at the top of this page) for journal specific policies. 
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For all journals, authors must include an “Availability of data and materials” section in 
their article detailing where the data supporting their findings can be found. If you do not 
wish to share your data, please state that data will not be shared, and state the reason. 
For instructions on how to cite your data and format this section see preparation/style and 
formatting. 
 
Competing interests 
All financial and non-financial competing interests must be declared in this section. See 
our editorial policies for a full explanation of competing interests. If you are unsure 
whether you or any of your co-authors have a competing interest please contact the 
editorial office. 
 
Funding 
All sources of funding for the research reported should be declared. The role of the funding 
body in the design of the study and collection, analysis, and interpretation of data and in 
writing the manuscript should be declared. 
 
Authors' contributions 
The individual contributions of authors to the manuscript should be specified in this 
section. Guidance and criteria for authorship can be found in our editorial policies. 
 
Acknowledgements 
Please acknowledge anyone who contributed towards the article who does not meet the 
criteria for authorship including anyone who provided professional writing services or 
materials. 
Authors should obtain permission to acknowledge from all those mentioned in the 
Acknowledgements section. 
See our editorial policies for a full explanation of acknowledgements and authorship 
criteria. 
Group authorship: if you would like the names of the individual members of a 
collaboration Group to be searchable through their individual PubMed records, please 
ensure that the title of the collaboration Group is included on the title page and in the 
submission system and also include collaborating author names as the last paragraph of 
the “Acknowledgements” section. Please add authors in the format First Name, Middle 
initial(s) (optional), Last Name. You can add institution or country information for each 
author if you wish, but this should be consistent across all authors. 
Please note that individual names may not be present in the PubMed record at the time a 
published article is initially included in PubMed as it takes PubMed additional time to 
code this information. 
 
Authors' information 
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You may choose to use this section to include any relevant information about the author(s) 
that may aid the reader's interpretation of the article, and understand the standpoint of the 
author(s). This may include details about the authors' qualifications, current positions they 
hold at institutions or societies, or any other relevant background information. Please refer 
to authors using their initials. Note this section should not be used to describe any 
competing interests. 
 
Endnotes 
Endnotes should be designated within the text using a superscript lowercase letter and all 
notes (along with their corresponding letter) should be included in the Endnotes section. 
Please format this section in a paragraph rather than a list. 
 
How to format your references 
Examples of the Vancouver reference style are shown below. Please ensure that the 
reference style is followed precisely; if the references are not in the correct style, they may 
need to be retyped and carefully proofread. 
 
Web links and URLs: All web links and URLs, including links to the authors' own 
websites, should be given a reference number and included in the reference list rather than 
within the text of the manuscript. They should be provided in full, including both the title 
of the site and the URL, as well as the date the site was accessed, in the following format: 
The Mouse Tumor Biology Database. http://tumor.informatics.jax.org/mtbwi/index.do. 
Accessed 20 May 2013. If an author or group of authors can clearly be associated with a 
web link, such as for weblogs, then they should be included in the reference. 
Authors may wish to make use of reference management software to ensure that reference 
lists are correctly formatted. An example of such software is Papers, which is part of 
Springer Science+Business Media. 
 
Example reference style: 
Article within a journal 
Smith JJ. The world of science. Am J Sci. 1999;36:234-5. 
Article within a journal (no page numbers) 
Rohrmann S, Overvad K, Bueno-de-Mesquita HB, Jakobsen MU, Egeberg R, Tjønneland 
A, et al. Meat consumption and mortality - results from the European Prospective 
Investigation into Cancer and Nutrition. BMC Medicine. 2013;11:63. 
Article within a journal by DOI 
Slifka MK, Whitton JL. Clinical implications of dysregulated cytokine production. Dig J 
Mol Med. 2000; doi:10.1007/s801090000086. 
Article within a journal supplement 
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Frumin AM, Nussbaum J, Esposito M. Functional asplenia: demonstration of splenic 
activity by bone marrow scan. Blood 1979;59 Suppl 1:26-32. 
Book chapter, or an article within a book 
Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne 
GH, Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 
1980. p. 251-306. 
OnlineFirst chapter in a series (without a volume designation but with a DOI) 
Saito Y, Hyuga H. Rate equation approaches to amplification of enantiomeric excess and 
chiral symmetry breaking. Top Curr Chem. 2007. doi:10.1007/128_2006_108. 
Complete book, authored 
Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of 
common illness. 3rd ed. Oxford: Blackwell Science; 1998. 
Online document 
Doe J. Title of subordinate document. In: The dictionary of substances and their effects. 
Royal Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate document. 
Accessed 15 Jan 1999. 
Online database 
Healthwise Knowledgebase. US Pharmacopeia, Rockville. 1998. 
http://www.healthwise.org. Accessed 21 Sept 1998. 
Supplementary material/private homepage 
Doe J. Title of supplementary material. 2000. http://www.privatehomepage.com. 
Accessed 22 Feb 2000. 
University site 
Doe, J: Title of preprint. http://www.uni-heidelberg.de/mydata.html (1999). Accessed 25 
Dec 1999. 
FTP site 
Doe, J: Trivial HTTP, RFC2169. ftp://ftp.isi.edu/in-notes/rfc2169.txt (1999). Accessed 12 
Nov 1999. 
Organization site 
ISSN International Centre: The ISSN register. http://www.issn.org (2006). Accessed 20 
Feb 2007. 
Dataset with persistent identifier 
Zheng L-Y, Guo X-S, He B, Sun L-J, Peng Y, Dong S-S, et al. Genome data from sweet 
and grain sorghum (Sorghum bicolor). GigaScience Database. 2011. 
http://dx.doi.org/10.5524/100012. 
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Appendix 2: Literature search strategies 
EMBASE 
1. (consent* adj3 research*).mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading] 
2. (accept* adj3 research*).mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading] 
3. (agree* adj3 research*).mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading] 
4. exp Emergency Medicine/  
5. (emergenc* adj1 medic*).mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading] 
6. exp Emergency Service, Hospital/  
7. (accident and emergency).mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading] 
8. a&e.mp. [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, 
drug manufacturer, device trade name, keyword, floating subheading]  
9. emergency department*.mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading] 
10. (emergenc* adj1 surg*).mp. [mp=title, abstract, heading word, drug trade name, original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading] 
11. (emergenc* adj1 operat*).mp. [mp=title, abstract, heading word, drug trade name, original 
title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading] 
12. (research* adj3 participat*).mp. [mp=title, abstract, heading word, drug trade name, original 
title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading] 
13. (emergenc* adj2 situation*).mp. [mp=title, abstract, heading word, drug trade name, original 
title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading] 
14. (informed consent* adj3 research*).mp. [mp=title, abstract, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword, floating 
subheading]  
15. 1 or 2 or 3 or 12 or 14  
16. 4 or 5 or 6 or 7 or 8 or 9 or 10 O 11.mp. or 13 [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword, 
floating subheading] 
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17. exp intensive care/ or critical care medicine.mp.  
18. exp emergency treatment/  
19. exp emergency care/  
20. exp emergency ward/  
21. 16 or 17 or 18 or 19 or 20  
22. 15 and 21  
23. limit 22 to (english language and embase and yr="1947 - current" and article) 
 
MEDLINE 
1. (consent* adj3 research*).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
2. (accept* adj3 research*).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
3. (agree* adj3 research*).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
4. exp Emergency Medicine/ 
5. (emergenc* adj1 medic*).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
6. exp Emergency Service, Hospital/  
7. (accident and emergency).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
8. a&e.mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms]  
9. emergency department*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
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10. (emergenc* adj1 surg*).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
11. (emergenc* adj1 operat*).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
12. (research* adj3 participat*).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
13. (emergenc* adj2 situation*).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
14. (informed consent* adj3 research*).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms]  
15. 1 or 2 or 3 or 12 or 14  
16. 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 13  
17. exp Emergency Treatment/  
18. emergenc* ward*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
19. emergenc* care*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
20. exp Critical Care/  
21. exp Critical Illness/  
22. critic* care medicin*.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]  
23. 16 or 17 or 18 or 19 or 20 or 21 or 22  
24. 15 and 23  
25. limit 24 to (english language and journal article and 1946-present) 
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PSYCHINFO 
1. (consent* adj3 research*).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures]  
2. (accept* adj3 research*).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
3. (agree* adj3 research*).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
4. 1 or 2 or 3  
5. exp Emergency Medicine/  
6. (emergenc* adj1 medic*).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures]  
7. exp Emergency Service, Hospital/  
8. (accident and emergency).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures]  
9. a&e.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests 
& measures]  
10. emergency department*.mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures]  
11. (emergenc* adj1 surg*).mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures]  
12. (emergenc* adj1 operat*).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures]  
13. (research* adj3 participat*).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures]  
14. (emergenc* adj2 situation*).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, original title, tests & measures]  
15. (informed consent* adj3 research*).mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures]  
16. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 14  
17. 4 or 13 or 15  
18. exp Intensive Care/  
19. critical* care*.mp. 
20. emergency* treatment*.mp.  
21. emergency* care*.mp.  
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22. emergency* ward*.mp.  
23. 16 or 18 or 19 or 20 or 21 or 22  
24. 17 and 23  
25. limit 24 to peer reviewed journal  
26. limit 25 to (peer reviewed journal and english language) 
27. limit 26 to yr="1860 -present" 
 
CINAHL 
S23 S20 AND S21  Limiters - Published Date: 19840101-20161231; 
English Language; Peer Reviewed; Publication Type: 
Journal Article; Language: English 
Search modes - Boolean/Phrase 
S22 S20 AND S21  Search modes - Boolean/Phrase 
S21 S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR 
S12 OR S13 OR S14 OR S16 OR S17 OR 
S18 OR S19  
Search modes - Boolean/Phrase 
S20 S1 OR S2 OR S3 OR S4 OR S5 OR S15  Search modes - Boolean/Phrase 
S19 (MH "Critical Care") OR "intensive care" OR 
(MH "Intensive Care Units")  
Search modes - Boolean/Phrase 
S18 (MH "Emergency Care") OR "emergency 
care"  
Search modes - Boolean/Phrase 
S17 "emergency ward"  Search modes - Boolean/Phrase 
S16 (MH "Emergency Treatment") OR 
"emergency treatment"  
Search modes - Boolean/Phrase 
S15 AB research* W3 participat*  Search modes - Boolean/Phrase 
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S14 AB emergenc* W2 situation*  Search modes - Boolean/Phrase 
S13 AB emergenc* W1 oper*  Search modes - Boolean/Phrase 
S12 AB emergenc* W1 surg*  Search modes - Boolean/Phrase 
S11 "emergency department"  Search modes - Boolean/Phrase 
S10 "a&e"  Search modes - Boolean/Phrase 
S9 "accident and emergency"  Search modes - Boolean/Phrase 
S8 AB emergenc* W1 medic*  Search modes - Boolean/Phrase 
S7 (MH "Emergency Service") OR "emergency 
service, hospital"  
Search modes - Boolean/Phrase 
S6 (MH "Emergency Medicine")  Search modes - Boolean/Phrase 
S5 AB informed consent* W3 research*  Search modes - Boolean/Phrase 
S4 AB agree* W3 research*  Search modes - Boolean/Phrase 
S3 AB accept* W3 research*  Search modes - Boolean/Phrase 
S2 AB consent* W3 research*  Search modes - Boolean/Phrase 
S1 (MH "Consent (Research)")  Search modes - Boolean/Phrase 
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Appendix 3: PICOS criteria tool 
PICOS TOOL INCLUDED EXCLUDED 
PATIENT 
POPULATION 
• ADULT PATIENTS (AGED 18 YEARS+)   
• INCLUDING WOMEN WHO ARE PREGNANT/OR 
DURING CHILDBIRTH IF MEDICAL EMERGENCY   
AND 
• REQUIRED EMERGENCY / LIFE THREATENING 
MEDICAL TREATMENT   
• PAEDIATRICS   
• PATIENTS WITH MINOR INJURIES IN AN EMERGENCY 
DEPARTMENT/SETTING   
• PSYCHIATRIC-RELATED MEDICAL EMERGENCIES   
• PATIENT POPULATION IS ED CONVIENANCE SAMPLE   
• UNCLEAR OF EXACT NATURE OF REASON FOR ADMISSION TO 
EMERGENCY DEPARTMENT   
INTERVENTIONS • INVITED TO ENROL IN EMERGENCY RESEARCH 
USING INFORMED CONSENT PROTOCOL   
 
• CONSENT PROTOCOL FOR USUAL PRACTICE CLINICAL 
PROCEDURES   
• CONSENT PROTOCOL FOR NON-EMERGENCY RESEARCH   
• CONSENT USING ‘EXCEPTION FROM CONSENT’ OR ‘PROXY’ 
PROTOCOLS   
COMPARATORS N/A N/A 
OUTCOMES • PATIENT EXPERIENCE /ATTITUDE/ 
PERCEPTION/VIEWS/OPINIONS   
• COMMUNITY CONSULTATION EXPERIENCE/ 
ATTITUDE/PERCEPTION/ VIEWS/ OPINIONS ONLY   
• SURROGATE DECISION MAKER EXPERIENCE/ ATTITUDE / 
PERCEPTION /VIEWS/OPINIONS ONLY   
• PARENT EXPERIENCE/ATTITUDE/PERCEPTION 
/VIEWS/OPINIONS   
STUDY DESIGN • QUALITATIVE STUDY   
• MIXED METHOD; QUALITATIVE METHOD   
• QUANTITATIVE OUTCOMES ONLY   
 
OVERALL 
DECISION 
YES       NO       
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Appendix 5: Submission guidelines for BMC Pregnancy and Childbirth 
 
Research article  
Criteria 
Research articles should report on original primary research, but may report on systematic 
reviews of published research provided they adhere to the appropriate reporting guidelines 
which are detailed in our editorial policies. Please note that non-commissioned pooled 
analyses of selected published research will not be considered. 
 
BMC Pregnancy and Childbirth strongly encourages that all datasets on which the 
conclusions of the paper rely should be available to readers. We encourage authors to ensure 
that their datasets are either deposited in publicly available repositories (where available and 
appropriate) or presented in the main manuscript or additional supporting files whenever 
possible. Please see Springer Nature’s information on recommended repositories. Where a 
widely established research community expectation for data archiving in public repositories 
exists, submission to a community-endorsed, public repository is mandatory. 
 
Preparing your manuscript 
The information below details the section headings that you should include in your 
manuscript and what information should be within each section. Please note that your 
manuscript must include a 'Declarations' section including all of the subheadings (please see 
below for more information). 
 
Title page 
The title page should: 
• present a title that includes, if appropriate, the study design e.g.: 
o "A versus B in the treatment of C: a randomized controlled trial", "X is a risk factor for 
Y: a case control study", "What is the impact of factor X on subject Y: A systematic 
review" 
o or for non-clinical or non-research studies a description of what the article reports 
• list the full names, institutional addresses and email addresses for all authors or if a collaboration 
group should be listed as an author, please list the Group name as an 
author. If you would like the names of the individual members of the Group to be 
searchable through their individual PubMed records, please include this information in 
the “Acknowledgements” section in accordance with the instructions below 
• indicate the corresponding author 
 
Abstract 
The Abstract should not exceed 350 words. Please minimize the use of abbreviations and 
do not cite references in the abstract. Reports of randomized controlled trials should follow 
the CONSORT extension for abstracts. The abstract must include the following separate 
sections: 
• Background: the context and purpose of the study 
• Methods: how the study was performed and statistical tests used 
• Results: the main findings 
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• Conclusions: brief summary and potential implications 
• Trial registration: If your article reports the results of a health care intervention on 
human participants, it must be registered in an appropriate registry and the registration 
number and date of registration should be in stated in this section. If it was not 
registered prospectively (before enrollment of the first participant), you should include 
the words 'retrospectively registered'. See our editorial policies for more information on 
trial registration 
 
Keywords 
Three to ten keywords representing the main content of the article. 
 
Background 
The Background section should explain the background to the study, its aims, a summary 
of the existing literature and why this study was necessary or its contribution to the field. 
 
Methods 
The methods section should include: 
• the aim, design and setting of the study 
• the characteristics of participants or description of materials 
• a clear description of all processes, interventions and comparisons. Generic drug names 
should generally be used. When proprietary brands are used in research, include the 
brand names in parentheses 
• the type of statistical analysis used, including a power calculation if appropriate 
 
Results 
This should include the findings of the study including, if appropriate, results of statistical 
analysis which must be included either in the text or as tables and figures. 
 
Discussion 
This section should discuss the implications of the findings in context of existing research 
and highlight limitations of the study. 
 
Conclusions 
This should state clearly the main conclusions and provide an explanation of the importance 
and relevance of the study reported. 
 
List of abbreviations 
If abbreviations are used in the text they should be defined in the text at first use, and a list 
of abbreviations should be provided. 
 
Declarations 
All manuscripts must contain the following sections under the heading 'Declarations': 
• Ethics approval and consent to participate 
• Consent for publication 
• Availability of data and material 
• Competing interests 
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• Funding 
• Authors' contributions 
• Acknowledgements 
• Authors' information (optional) 
Please see below for details on the information to be included in these sections. 
If any of the sections are not relevant to your manuscript, please include the heading and 
write 'Not applicable' for that section. 
 
Ethics approval and consent to participate 
Manuscripts reporting studies involving human participants, human data or human tissue 
must: 
• include a statement on ethics approval and consent (even where the need for approval 
was waived) 
• include the name of the ethics committee that approved the study and the committee’s 
reference number if appropriate. 
Studies involving animals must include a statement on ethics approval. See our editorial 
policies for more information. If your manuscript does not report on or involve the use of 
any animal or human data or tissue, please state “Not applicable” in this section. 
 
Consent for publication 
If your manuscript contains any individual person’s data in any form (including individual 
details, images or videos), consent for publication must be obtained from that person, or in 
the case of children, their parent or legal guardian. All presentations of case reports must 
have consent for publication. 
You can use your institutional consent form or our consent form if you prefer. You should 
not send the form to us on submission, but we may request to see a copy at any stage 
(including after publication). See our editorial policies for more information on consent for 
publication. If your manuscript does not contain data from any individual person, please state 
“Not applicable” in this section. 
 
Availability of data and materials 
All manuscripts must include an ‘Availability of data and materials’ statement. Data 
availability statements should include information on where data supporting the results 
reported in the article can be found including, where applicable, hyperlinks to publicly 
archived datasets analysed or generated during the study. By data we mean the minimal 
dataset that would be necessary to interpret, replicate and build upon the findings reported 
in the article. We recognise it is not always possible to share research data publicly, for 
instance when individual privacy could be compromised, and in such instances data 
availability should still be stated in the manuscript along with any conditions for access. 
Data availability statements can take one of the following forms (or a combination of more 
than one if required for multiple datasets): 
• The datasets generated and/or analysed during the current study are available in the 
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